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palavras-chave 
 
Sistemas compartimentais, controlo positivo, sistemas com incertezas, 
observadores do estado, controlo do bloqueio neuromuscular. 
 
resumo 
 
 
Os sistemas compartimentais são frequentemente usados na modelação de 
diversos processos em várias áreas, tais como a biomedicina, ecologia, 
farmacocinética, entre outras.  
 
Na maioria das aplicações práticas, nomeadamente, aquelas que dizem 
respeito à administração de drogas a pacientes sujeitos a cirurgia, por 
exemplo, a presença de incertezas nos parâmetros do sistema ou no estado 
do sistema é muito comum. Ao longo dos últimos anos, a análise de sistemas 
compartimentais tem sido bastante desenvolvida na literatura. No entanto, a 
análise da sensibilidade da estabilidade destes sistemas na presença de 
incertezas tem recebido muito menos atenção.  
 
Nesta tese, consideramos uma lei de controlo por realimentação do estado 
com restrições de positividade e analisamos a sua robustez quando aplicada a 
sistemas compartimentais lineares e invariantes no tempo com incertezas nos 
parâmetros. Além disso, para sistemas lineares e invariantes no tempo com 
estado inicial desconhecido, combinamos esta lei de controlo com um 
observador do estado e a robustez da lei de controlo resultante também é 
analisada. 
 
O controlo do bloqueio neuromuscular por meio da infusão contínua de um 
relaxante muscular pode ser modelado como um sistema compartimental de 
três compartimentos e tem sido objecto de estudo por diversos grupos de 
investigação. Nesta tese, os nossos resultados são aplicados a este problema 
de controlo e são fornecidas estratégias para melhorar os resultados obtidos. 
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abstract 
 
Compartmental systems are widely used for modeling several processes in 
many fields such as biomedicine, ecology, pharmacokinetics, among others.  
 
In most practical applications, as for instance those concerning drug 
administration to patients undergoing surgery, the presence of uncertainties in 
the system parameters or in the system state is very common. Over the last 
several years the analysis of compartmental systems has been widely 
developed in the literature. However, the analysis of the sensitivity of the 
stability of these systems under the presence of uncertainties has received far 
less attention.  
 
In this thesis, we consider a state feedback control law with positivity 
constraints and analyze its robustness when applied to linear time-invariant 
compartmental systems with parameter uncertainties. Moreover, for linear time-
invariant compartmental systems with unknown initial state, we combine this 
control law with a state-observer and the robustness of the resulting control law 
is also analyzed. 
 
The control of the neuromuscular blockade by the continuous infusion of a 
muscle relaxant may be modelled as a three-compartment system and has 
been a subject of study by several research groups. In this thesis, our results 
are applied to this control problem and strategies for improving the obtained 
results are provided. 
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Introduction
Compartmental systems consist of a finite number of subsystems, the compartments,
which exchange matter with each other and with the environment. Their state is character-
ized by the amount of matter in each compartment ([Godfrey (1983)] or [Sandberg (1978)]).
Figure 1 illustrates a general structure of such systems.
Figure 1: General structure of a compartmental system. The fij are flow rates from compartment
i to compartment j. Compartment 0 is the environment.
For this reason, the state components and the flow rates between compartments must
be nonnegative and, therefore, these systems are a particular case of positive systems,
i.e., systems for which the state variables take only nonnegative values (see, for instance,
[Farina and Rinaldi (2000)]).1
In many fields (biomedicine, ecology, pharmacokinetics, among others), it is possible to
find several examples of compartmental systems applications.
In [Haddad et al (2010)], a linear four-compartment model is given for a forest ecosys-
tem dynamic. In this model, the four compartments correspond to leaves, debris, soil
and wood. According to the author, the flows between compartments correspond to the
1Due to the definition of positive systems, some authors (see [Haddad et al (2010)], for instance) refer
to these systems as nonnegative dynamical systems. However, in this thesis, the most common term will
be used instead, i.e., these systems will be called positive systems.
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following scenario: leaves fall and contribute to forest debris, which decomposes into soil.
The nutrients from the soil are converted into wood and leaves. Input and output flows
occur primarily to and from the soil compartment. In Fig. 2, each compartment contains
a concentration of potassium.
Figure 2: Four-compartment model of potassium flow in a forest.
In [Godfrey (1983)], an extensive application of compartmental systems in biomedicine
may be found along with examples for linear and nonlinear approaches. Several schemes
for connections between compartments are proposed, illustrating a large range of com-
partmental models structure. A nonlinear compartmental model of calcium metabolism is
presented, being its structure as represented in Fig. 3. The only nonlinearity presented
corresponds to the part of the model that represents bone growth. Compartment 1 con-
tains the plasma, compartments 2, 3 and 4 are bone compartments and compartment 5 is
a compartment that interacts with compartment 1.
Figure 3: Five-compartment model of calcium metabolism.
In [Bastin and Provost (2002)], reference is made to an industrial grinding circuit used
in cement industries that is made up of the interconnection of a ball mill and a separator.
iv
The ball mill is fed with raw material and, after grinding, the milled material is introduced
in a separator where the finished product is separated from the oversize particles which
are recycled to the ball mill. The structure of the model proposed for this system is
represented in Fig.4. Here, compartment 1 corresponds to the finished product in the
separator, compartment 2 corresponds to the amount of oversize particles in the separator,
compartment 3 corresponds to the amount of material in the ball mill and u represents the
feeding rate.
Figure 4: Compartmental model associated to an industrial grinding circuit.
In [Bailey and Shafer (1991)], [Absalom and Struys (2007)], [Kansanaho et al (1997)],
[Jacobs (1988)], [Haddad et al (2003)], [Haddad et al (2006)], among others, reference is
made to the behavior of anesthetic drugs. This behavior may usually be described by a two
or a three-compartment model and the most common pharmacokinetic models2 are linear
and mammilary, that is, they consist of a central compartment with peripheral compart-
ments connecting to it and there are no interconnections among other compartments. In
Fig. 5 an example of a model with three compartments is represented. The drug is injected
Figure 5: Example of a three-compartment model that describes the behavior of anesthetic drugs
2A pharmacokinetic model describes the absortion, distribution, metabolism and elimination of the
drug by the body.
v
into the central compartment and k12, k21, k13, k31, q1, q2, q3 are nonnegative micro-rate con-
stants that vary from patient to patient. In this model, the rate constant q1 corresponds to
metabolism or elimination and the rate constants kij correspond to drug transfer between
compartments. In [Jacquez and Simon (1993)] a two-compartment mammilary system is
proposed for the same purpose.
The dynamics of compartmental systems have been extensively treated in the literature
(see, for instance, [Jacquez and Simon (1993)], [Farina and Rinaldi (2000)], [Fife (1972)]
and [Godfrey (1983)]), and, although there are far less results concerning the control of
such systems, this is a field that is receiving an increasing interest.
As it was already mentioned, the compartments of a compartmental system exchange
matter with each other and with the environment. Therefore, since the quantity of ma-
terial that is exchanged, as well as the quantity or concentration of material inside each
compartment, cannot be negative, one has to be very careful when choosing a control law,
since the positivity of the state components has to be guaranteed. This is ensured when
the control input is taken to be positive. However, the requirement of positivity of the con-
trol variables may constitute a serious obstacle for the achievement of the desired control
purposes (for instance, stabilization and reference tracking).
There are several studies concerning the control of compartmental systems via a positive
control input. For instance, in [Haddad et al (2003)] an adapted control law, for linear non-
negative and compartmental systems, with nonnegative control is proposed and it is shown,
using Lyapunov-based methods that it leads to the partial asymptotic set-point stability of
the closed-loop system, that is, to the asymptotic stability with respect to the states asso-
ciated with the process dynamics. In [Haddad et al (2006)], the same author presents an
extension of this result to nonlinear compartmental systems. In [Bastin and Praly (1999)]
and [Bastin and Provost (2002)] a positive feedback control law is proposed in order to sta-
bilize the total system mass (that is, the sum of the quantity or concentration of material
that exists in each compartment) at an arbitrary set-point and, in [Magalhães et al (2005)],
this control law is applied to the control of the neuromuscular blockade. However, accord-
ing to some authors (see, for instance, [De Leenheer and Aeyels (2001)]), the positivity
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constraint for the input is not natural in many applications of positive systems (includ-
ing compartmental systems), namely in biology, where the state components typically are
concentrations of interacting species and a nonnegative input in this context would mean
that all species could only be fed and could never be killed. In these cases, the authors
considered that it makes sense to allow the input to achieve nonnegative values if that
does not destroy the positivity of the system state. Nevertheless, this issue is only possible
for closed - loop schemes. Indeed, if the initial state of the system belongs to the inte-
rior of the positive orthant, then, by continuity, the state trajectories will remain inside
the orthant during a small interval of time, even if the input sometimes take nonnegative
values; when the initial state belongs to the boundary of the positive orthant, there is
information on the present state (since it is a closed-loop scheme) and the anticipation of
the loss of system positivity is possible; on the other hand, in an open-loop scheme there
is no information on the present state and this fact forces the input to be nonnegative to
guarantee that the system is positive. In accordance to this considerations, the authors in
[De Leenheer and Aeyels (2001)] allow negative inputs for feedback in order to stabilize the
system states, requiring that the resulting closed-loop system is a positive one; moreover,
in [Haddad et al (2003)] an adaptive controller was developed for linear nonnegative and
compartmental systems and, although the controller sign was not restricted, it guarantees
the positivity of the resulting system.
In this thesis, the input of compartmental systems will be considered to be nonnegative,
in accordance to the definition that was presented. The main reason for considering this
constraint is our aim to apply the underlying results to the control of the infusion of the
neuromuscular relaxant drug atracurium to patients undergoing surgery. In these cases,
the input flow represents quantity of drug, thus it has to be nonnegative.
During general anesthesia, three main groups of anesthetic agents are usually admin-
istered: hypnotics agents, analgesics and muscle relaxants. Hypnotics agents, also known
as induction agents, produce unconsciousness and sedation (an example is propofol), anal-
gesics (for instance, fentanyl) are used to relieve pain and to achieve a good state of
analgesia and muscle relaxants allow to achieve an adequate relaxation level (atracurium
is an example of a muscle relaxant that blocks nerve impulses so that muscles cannot
contract). Manual administration of the dose implies that the anesthetist has to make
vii
timely adjustments to the infusion pump to ensure that the correct effect is maintained.
Therefore, in order to turn the control of the dose administered during general anesthesia
easier and safer, an infusion method named target controlled infusion (TCI) was developed
(see [Absalom and Struys (2007)]). This control process is implemented by means of a
computerized system whose basic components are:
• a user interface;
• a computer or one or more micro-processors that are programmed with mean or
populational models that mathematically describe drug distribution and elimination
(see Fig. 5);
• an infusion device.
In this open-loop control process the anesthetist may directly define the desired infusion
rate or even the target effect or plasma concentration. In these cases, the TCI pumps set
and adjust the needed dose to achieve it. However, during this process, the anesthetist
is free to redefine and change a target concentration, according to his experience and
the clinical observations of the patient. An extensive overview of TCI, target controlled
infusions devices, is presented in [Absalom and Struys (2007)].
The mathematical models presented on the device for individualized drug administra-
tion should be patient-dependent. Since it is not possible to identify the patient parameters,
TCI devices use population information to derive the desired infusion profile in order to
achieve the target. Therefore, the dose profile is predicted by validated population models
and, during a TCI procedure, the true current plasma concentrations are not measured
and, hence, are not available for feedback purposes. As a matter of fact these systems are
open-loop systems and do not compensate when the populational models and the patient
dynamics are too different. It turns out that, in this situation they are not adequate for
individualized target drug administration ([Ting et al (2004)]). Moreover, when consid-
ering an anesthetic drug, the control of drug effect is very important, since overdosing
can delay recovery from anesthesia or result in respiratory and cardiovascular collapse and
underdosing can cause psychological trauma from awareness and pain during surgery (see
[Haddad et al (2003)]). In this framework, feedback control for drug administration is
receiving increasing attention.
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In [Dumont et al (2009)] the design of robust controllers based on fractional calculus
is considered in order to regulate the hypnotic state of anesthesia with the intravenous
administration of propofol. The resulting closed-loop control system can be proven to be
stable and to provide performance bounds for a population that falls within a specified
uncertainty range; in [Silva et al (2009)], a control strategy based on several techniques is
presented in order to improve the obtained results concerning the control of the neuromus-
cular blockade level of patients undergoing surgery. This control strategy computes the
adequate drug dosage regimen that drives the drug effect to a desired target in a prespeci-
fied period of time and determines the loading dose that should be administered to control
the system around that working point; as already mentioned, in [Bastin and Praly (1999)]
and [Bastin and Provost (2002)] it is proved that the proposed state feedback control law
with positivity constraints stabilizes the total system mass at a desired set-point and, in
[Magalhães et al (2005)], this control law is applied to the particular control of the neu-
romuscular blockade level with very good results. Indeed, it is shown that, due to the
particular structure of the correspondent three-compartment model, the use of a control
law that stabilizes the total mass of the system allows to control the aforementioned level,
leading it to the desired target value. However, no analysis was made of the effect of
parameter and state uncertainties in its performance.
Although the robustness of the control law is not analyzed, the results presented in
[Magalhães et al (2005)] showed that the control law proposed in [Bastin and Praly (1999)]
and [Bastin and Provost (2002)] was a very strong candidate to the control of the neuro-
muscular blockade level of patients undergoing surgery by means of the continuous infusion
of the muscle relaxant drug atracurium. This is a situation where robustness is a relevant
issue, since patient models are highly subject to uncertainties. Indeed, parameter and state
uncertainties are present not only in this case, but in most of the applications. Some re-
sults concerning the control of systems with parameters uncertainties have been published
(for instance, in [Xie and Soh (1995)], the problem of designing a linear dynamic output
feedback controller that robustly stabilizes an uncertain linear time-invariant system is
addressed and, in [Haddad et al (2003)], an already mentioned adapted control law is gen-
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eralized to uncertain nonnegative and compartmental systems), but robustness properties
of positive and compartmental systems have been largely ignored.
When the system state cannot be determined by direct observation, we often use a state-
observer to estimate the state from the knowledge of the input and the output of the real
system. The concept of an observer for a dynamic system was introduced by Luenberger,
in [Luenberger (1964)] and, in [Luenberger (1979)], the observer problem for general linear
systems 3 has been completely solved. Although in [Luenberger (1979)] no constraints on
the observer sign have been considered, there are several studies concerning positive ob-
servers. For instance, in [Back and Astolfi (2006)] it is shown that a positive linear system
only admits a linear and positive Luenberger type observer if the number of nonnegative
real eigenvalues of the system matrix is at most one; in [Härdin and van Schuppen (2007)],
the synthesis of linear observers and positive linear observers for linear positive systems
is considered; in [Back et al (2006)], the authors propose a new structure (different from
a Luenberger type) of a positive linear observer for single output compartmental systems
which requires only the detectability condition and analyze the existence of a luenberger
type positive linear observer for linear positive systems.
In this thesis, we will only consider fully outflow connected compartmental systems,
that is, systems for which each compartment is always connected to the exterior, via a
positive outflow from that compartment or via the connection to another compartment
with a positive outflow. For this kind of systems it is possible to prove that the con-
dition for the existence of a positive and linear Luenberger type observer for a positive
linear system, presented in [Back and Astolfi (2006)], is verified. However, the positiv-
ity constraint on the observer will not be required. Some authors (see, for instance, in
[Härdin and van Schuppen (2007)]), when asked to clarify why they prefer a positive ob-
server for a positive systems, refer the interpretation of the observer states but, in this
thesis, we will combine a state-observer with a control law that remains nonnegative, even
if the observer is not. Thus, when this control law is applied to the control of the neu-
romuscular blockade level of patients undergoing surgery, the positivity of the controlled
system is not destroyed.
3The purpose of this problem is to determine a linear observer such that the system state can be
approximated, i.e., such that the difference between the state and its estimate converges to zero.
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Motivated by the good results obtained in [Magalhães et al (2005)] concerning the ap-
plication of the control law proposed in [Bastin and Praly (1999)] to the control of the
neuromuscular blockade level of patients undergoing surgery, in this thesis we analyze the
performance of the proposed control law, when applied to compartmental systems with
uncertainties, contributing to set a theoretical foundation for the practical implementation
of control procedure. For this purpose, the systems under consideration will be linear
time-invariant and fully outflow connected compartmental systems.
The outline of this thesis follows. The thesis has five main chapters and a sixth one
dedicated to the main contributions and future work. In the first main chapter (Chapter 1)
a brief overview of the systems under consideration is presented. A summary of the state
of the art concerning published theoretical results that will be used to prove our own new
results is also carried out. The second main chapter (Chapter 2) presents a brief description
of a particular compartmental model: a model for the infusion of a neuromuscular blocker,
based on which several control laws were designed in order to achieve a desired neuromus-
cular blockade level. In the third and fourth main chapters (Chapter 3 and Chapter 4) the
implications of parameter uncertainties are studied. Indeed, we consider the state feedback
control law with positivity constraints (proposed in [Bastin and Praly (1999)] and Bastin)
tuned for a nominal system and prove that this law leads the total mass of the real system
to a neighborhood of the desired value. The range depends on the parameter uncertainties
and can be made arbitrarily small when the uncertainties are sufficiently small. Moreover,
for a class of three-compartment systems with the same structure as the neuromuscular
blockade control model, it has been proved that the state of the controlled system tends
to an equilibrium point whose total mass lies within the aforementioned interval. Due to
the high variability of patient parameters, this result is a step ahead to the robustness
of the control law designed for individualized drug administration. In Chapter 4 we also
present two ways of improving our control results, for this wide class of three-compartment
systems:
• taking into account the relationship between the mass and the state components in
steady state, it is possible to adapt the proposed mass control law during the control
procedure to track the desired values for the steady state components. In this way
we obtain a novel method for steady-state control via total mass control;
xi
• for the particular case of the neuromuscular blockade control, a combination of several
methods published in literature is used.
In the last main chapter (Chapter 5), the performance of state-observers in the control of
compartmental systems under the presence of uncertainties in the initial system state is
also analyzed. We combine the aforementioned state feedback control law with a state-
observer and prove that, as expected, the mass control objective is still attained. Moreover,
for the class of three-compartment systems with the same structure as the neuromuscular
blockade control model, we show that the resulting mass control law also allows reaching
a desired steady state.
Our results are illustrated by several simulations for the control of a neuromuscular
relaxant administration to patients undergoing surgery and a real case performed in the
surgery room is also presented. In Chapter 5, the simulations study show the relevance
of incorporating an observer for convergence acceleration in case the original system is
already asymptotically stable.
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Chapter 1
Compartmental Systems: a brief
overview
In this chapter some basic definitions concerning compartmental systems are presented
together with an overview of the stability of such systems and of the previous work related
to the control of their total mass.
1.1 Basic definitions
Compartmental models have been successfully used to model biomedical and phar-
macokinetical systems (see, for instance, [Godfrey (1983)] or [Jacquez and Simon (1993)]).
This kind of dynamical systems consist of a finite number of subsystems, the compartments,
which exchange matter with each other and with the environment, and are described by a
set of equations of the form
x˙i =
∑
j 6=i fji(x)−
∑
l 6=i fil(x)− fi0(x) + f0i(x)
i = 1, . . . , n
(see [Godfrey (1983)] or [Sandberg (1978)]) where x = [x1 . . . xn]T is the state variable and
xi and fij take nonnegative values. Each equation describes the evolution of the quantity
or concentration of material within a compartment. Since the compartments exchange
matter with each other and with the environment, in the above equation, xi is the amount
(or concentration) of material in compartment i, fij is the flow rate from compartment i
1
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to compartment j and 0 denotes the environment (see [Godfrey (1983)]). In this thesis,
we consider the class of linear time-invariant compartmental systems described by
x˙i =
∑
j 6=i
kjixj −
∑
l6=i
kilxi − qixi + biu(x), i = 1, . . . , n, (1.1.1)
where xi and the input u take nonnegative values, the rate constants, kij, as well as qi, bi
are nonnegative and at least one bi is positive (see Fig. 1.1).
Figure 1.1: Two compartments of a linear time-invariant compartmental model, as described by
(1.1.1)
Note that, in this case, fji(x) = kjixj, f0i(x) = biu(x) and fi0(x) = qixi, and it can
be easily proved that the system verifies the following properties (which are widely
documented in the literature):
i) it is positive, that is, if we consider a nonnegative initial state and an input u that
remains nonnegative, then the state variable also remains nonnegative;
The following proof may be found in [Bastin and Guffens (2006)], for instance. However,
it will be presented here in order to keep this thesis as much self-contained as possible.
Proof. Suppose that x(t) reaches the boundary of the positive orthant at time t = t∗.
Then some of the components of x(t∗) are zero while the others may be greater than zero.
Moreover, if xi(t∗) = 0,
x˙i(t∗) =
∑
j 6=i kjixj(t∗) + biu(t∗) ≥ 0.
Thus, xi does not decrease and remains nonnegative.
1.1 Basic definitions 3
ii) (1.1.1) can be written in matrix form as
x˙ = Ax+ bu, (1.1.2)
where A is such that
aii = −qi −
∑
j 6=i
kij and, if i 6= j, aij = kji,
and b = [b1 b2 . . . bn]T . Note that A verifies the following conditions: if i 6= j aij ≥ 0,
aii ≤ 0 and A is diagonally dominant, that is,
|aii| −∑nj=1,j 6=i aji ≥ 0;
matrices for which these conditions hold are called compartmental matrices; more-
over, the sum of all the entries in the ith column of A equals −qi.
iii) if u ≡ 0 and if the system is fully outflow connected, (that is, for every compartment
i with qi = 0 there is a chain i → j → k → · · · → l with positive rate constants at
each step and with ql > 0), then
limt→+∞x(t) = 0,∀x(t) : x(0) ∈ ℝn+.
(see [Eisenfeld (1982)] and [Bastin and Provost (2002)], for instance).
The proof of this third property is based on LaSalle’s invariance principle ([LaSalle (1976)],
pg.30). In order to state this important result, some needed results and notations will be
presented first (these results may also be found in [LaSalle (1976)]).
Let G∗ be an open set in ℝn and let f : G∗ → ℝn be a continuous function.
Definition 1.1.1. Consider V : G∗ → ℝ and let G be any subset of G∗. V is said to be a
LaSalle-Lyapunov function of
x˙ = f(x) (1.1.3)
on G if:
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1. V is continuous;
2. V˙ (x) = dV (x)
dt
≤ 0,∀x ∈ G.
Definition 1.1.2. A set H ⊂ ℝn is said to be (positively) invariant with respect to (1.1.3)
if x(t1) ∈ H ∩G∗ implies that x(t) ∈ H ∩G∗ for all t ≥ t1 (being t1 some nonnegative
instant time and x(t) a solution of (1.1.3)).
Notation 1.1.3. Let G denote the reunion of G with its boundary and let
E =
{
x ∈ G ∩G∗ : V˙ (x) = 0
}
.
The largest invariant set in E will be denoted by N .
Definition 1.1.4. Let x : ℝ+0 → G∗ be a solution of (1.1.3).
1. A point P is said to be a positive limit point of x if there is a sequence tn ∈ ℝ+0 such
that tn → +∞ and x(tn)→ P .
2. x is said to be positively precompact if it is bounded for all t ∈ ℝ+0 and has no positive
limit points on the boundary of G∗.
It follows from LaSalle’s invariance principle (see [LaSalle (1976)], pg.30) that if V is a
LaSalle-Lyapunov function of (1.1.3) on G, then any positively precompact solution of the
system that remains in G converges to N . This is stated in the following theorem.
Theorem 1.1.5. (LaSalle’s invariance principle) Let V be a LaSalle-Lyapunov function
of (1.1.3) on G and let x(t) be a solution of this system that remains in G for all t ≥ 0.
Then, if x(t) is positively precompact, ∃c : x(t)→ N ∩ V −1(c), as t→ +∞.
Now, a proof of the property iii) of compartmental systems will be presented.
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Proof. To prove this result we take G∗ = ℝn, f(x) = Ax and G = ℝn+. Then, as pointed
out in [Bastin and Praly (1999)] and [Bastin and Provost (2002)], for instance, the total
mass of the compartmental system in a given state x,
M(x) = ∑ni=1 xi,
is a LaSalle-Lyapunov function of x˙ = Ax on ℝn+ (see Definition 1.1.1), since it is continuous
and
M˙(x) = −∑ni=1 qixi ≤ 0,∀t ≥ 0.
Let x(t) be a solution of x˙ = Ax with x(0) ∈ ℝn+. Since this system is a particular case
of (1.1.1), it is positive. Thus x(t) ∈ ℝn+,∀t ≥ 0. Moreover, x(t) is bounded,∀t ≥ 0,
because if it were not, M(x(t)) would tend to +∞, which does not happen, since M˙(x) =
−∑ni=1 qixi ≤ 0. Also note that x has no limit points on the boundary of ℝn. Therefore,
LaSalle’s invariance principle (see Theorem 1.1.5) allows us to conclude that
∃c : x(t)→ N ∩M−1(c),
being N the largest invariant set of
{
x ∈ ℝn+ : M˙(x) = 0
}
.
Note that
M˙(x) = 0⇔ qixi = 0,∀i = 1, . . . , n⇔ qi = 0 ∨ xi = 0,∀i = 1, . . . , n.
Suppose that ∃t1 > 0 : M˙(x(t1)) = 0. Assume further that, at the instant t1, there is a
compartment j such that xj(t1) 6= 0. Then, qj = 0 and kji > 0, being i a compartment
such that qi > 0 (the existence of such an instant is guaranteed because the system is
fully outflow connected). Note that qi is constant. Thus, its positivity implies that xi ≡ 0.
However,
x˙i =
∑
j 6=i kjixj > 0,
which means that xi will become positive imediatly after t1. This absurd is a result of
having assumed that there is a compartment j such that xj(t1) 6= 0. Thus, x ≡ 0 is the
only trajectory contained in the set
{
x : M˙(x) = 0
}
and the proof is concluded.
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In this thesis, we shall only consider fully outflow connected systems.
1.2 Stability
In this section, some results concerning the stability of compartmental systems are
presented.
Definition 1.2.1. Given a system of the form (1.1.3), x∗ is said to be an equilibrium point
of (1.1.3) if x ≡ x∗ is a solution of that equation.
Lemma 1.2.2. x∗ is an equilibrium point of (1.1.3) if and only if f(x∗) = 0.
Clearly, x∗ = 0 is an equilibrium point of the system
x˙ = Ax (1.2.1)
.
Definition 1.2.3. An equilibrium point x∗ of the system (1.1.3) is said to be:
i) stable if
∀U ∃V : x(0) ∈ V ⇒ x(t) ∈ U ,∀t ≥ 0
where U and V are neighborhoods of x∗;
ii) (globally) asymptotically stable if it is stable and:
limt→+∞x(t) = x∗,∀x(t) : x(0) ∈ ℝn.
Definition 1.2.4. Given a system of the form (1.2.1), it is (asymptotically) stable if x∗ = 0
is an equilibrium point (asymptotically) stable.
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A system of the form (1.1.2) is said to be (asymptotically) stable if (1.2.1) is (asymptot-
ically) stable. If the system is asymptotically stable, the matrix A is said to be stable. It
is well known that, if σ(A) represents the set of all eigenvalues of a given square matrix A
(spectrum of A), then, (1.2.1) is asymptotically stable if and only if all the eigenvalues of A
have negative real part, that is, if σ(A) ⊂ ℂ-, and it is stable if and only if all eigenvalues of
A have non positive real part and those with zero real parts verify the additional condition
that their algebraic and geometric multiplicities coincide (see, for instance, [Chen (1999)]).
Moreover, by using Gers˘gorin theorem it is possible to locate the eigenvalues of a square
matrix, as follows.
Theorem 1.2.5. [Gers˘gorin (1931)] and [Horn and Johnson (1985)] Let A = [aij] be a
square matrix with dimension n and define
Ri(A) =
∑
j 6=i |aij| , i = 1, . . . , n.
Then, all the eigenvalues of A belong to the following set:
⋃n
i=1 {z ∈ ℂ : |z − aii| ≤ Ri(A)}.
Therefore, if A is diagonally dominant, that is,
|aii| −∑nj=1,j 6=i aji ≥ 0,
and if all its diagonal entries are non positive, we may conclude that the real part of all the
eigenvalues is non positive and, if there is an eigenvalue with zero real part, this eigenvalue
must be real and hence be equal to zero. Note that a compartmental matrix verifies these
conditions. Moreover, in [Haddad et al (2010)] the following result is proved.
Proposition 1.2.6. Given a compartmental system of the form (1.2.1), the algebraic and
geometric multiplicity of 0 ∈ σ(A) are equal.
Therefore, the compartmental systems of the form (1.1.2) are always stable and will be
asymptotically stable if and only if A is invertible.
In physical terms, asymptotical stability of compartmental systems is equivalent to fully
outflow connectedness (this was proved in [Fife (1972)] and [Jacquez and Simon (1993)]).
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1.3 Total mass control
The total mass of a compartmental system in a given state x is defined as M(x) =∑
n
i=1 xi. For an arbitrary positive value M∗, the set
ΩM∗ =
{
x ∈ ℝn+ : M(x) = M∗
}
of all the points x in the state space with massM∗ is called an iso-mass. If u ≡ 0, property
iii) of compartmental systems, presented in Section 1.1, guarantees that the mass does not
accumulate inside the system. However, this may not happen if u is not always zero. This
undesired situation is avoided if one is able to stabilize the total mass of the system in a
given positive target value M∗, or equivalently, lead the state trajectories to the iso-mass
ΩM∗ . This leads us to an important issue in the context of the control of compartmental
systems: to design a control law which yields a positive input that steers the system mass
M(x) to a desired target valueM∗. Note that, if there were not input positivity constraints,
the control law
u(x) =
(
n∑
i=1
bi
)−1 ( n∑
i=1
qixi + λ (M∗ −M(x))
)
, (1.3.1)
where λ is an arbitrary positive design parameter, would allow us to achieve our goal.
Indeed, in this case, the closed-loop compartmental equations would be described by:
x˙ = Ax+ b
(
n∑
i=1
bi
)−1 ( n∑
i=1
qixi + λ (M∗ −M(x))
)
(1.3.2)
and the closed-loop mass equation would be:
M˙(x) = λ (M∗ −M(x))
Thus,
•︷ ︸︸ ︷
M∗ −M(x) = −λ (M∗ −M(x))
and, M(x) would go to M∗ as desired. However, as mentioned at the beginning of this
chapter (section 1.1), there is an input positivity constraint. In this case, it is not possible to
use the aforementioned control law. In this framework, a nonnegative adaptive control law
is proposed in [Haddad et al (2003)], in order to guarantee the asymptotic stability with
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respect to the states associated with the process dynamics. In [Bastin and Praly (1999)]
and [Bastin and Provost (2002)], the following positive alternative feedback control law:
u(x) = max (0, u˜(x))
u˜(x) = (∑ni=1 bi)−1 (∑ni=1 qixi + λ (M∗ −M(x))) , (1.3.3)
where λ is an arbitrary design parameter, is proposed in order to stabilize the total system
mass at an arbitrary set-point. The desired convergence properties, concerning control law
(1.3.3), are obtained through the following result.
Theorem 1.3.1. [Bastin and Praly (1999)],[Bastin and Provost (2002)] Let (1.1.2) be a
fully outflow connected compartmental system andM∗ be an arbitrary positive value. Then,
for the closed loop system (1.1.2)-( 1.3.3) with arbitrary initial conditions x(0) ∈ ℝn+:
i) the iso-mass ΩM∗ is invariant;
ii) the state x(t) is bounded for all t > 0 and converges to the iso-mass ΩM∗.
The proof of this theorem is based on the application of LaSalle’s invariance principle
(see Theorem 1.1.5), by considering the LaSalle-Lyapunov function
V (x) = 12 (M
∗ −M(x))2
of (1.1.2) on ℝn+. We present here this proof to make the reader more familiar with this
kind of reasoning, since we shall make use of an adapted version of this function in our
convergence analysis.
Proof.
i) Suppose that there is a time instant t1 such that x(t1) ∈ ΩM∗ . Note that
x(t1) ∈ ΩM∗ ⇒M(x(t1)) = M∗
and u(x(t1)) = (
∑
n
i=1 bi)
−1 (∑n
i=1 qixi(t1)). Thus,
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M˙(x(t1)) = −∑ni=1 qixi(t1) + (∑ni=1 bi)u(x(t1)) = 0
and x(t) ∈ ΩM∗ ,∀t ≥ t1.
ii) Define V = 12 (M
∗ −M(x))2. Then,
V˙ (x) = − (M∗ −M(x)) M˙(x)
and
• if u˜(x) < 0, then u(x) = 0 and M(x) > M∗. Thus, V˙ (x) ≤ 0.
• if u˜(x) = u(x) ≥ 0, then M˙(x) = −∑ni=1 qixi + (∑ni=1 bi)u(x) = λ (M∗ −M(x))
and V˙ (x) ≤ 0.
Applying LaSalle’s Invariance Principle (see Theorem 1.1.5), it turns out that the sys-
tem trajectories converge to the largest invariant set contained in
E =
{
x ∈ ℝn+ : V˙ = 0
}
.
However, V˙ = 0 if and only if M(x) = M∗ or if {u(x) = 0,M(x) > M∗and∑ni=1 qixi = 0}.
This means that
E =
{
x ∈ ℝn+ : M(x) = M∗
}
∪ E˜,
with
E˜ =
{
x ∈ ℝn+ : u(x) = 0,M(x) > M∗ and
∑n
i=1 qixi = 0
}
.
Suppose that E˜ is an invariant subset of E. Then, since system (1.1.2) is fully outflow
connected, M(x) → 0. However, in E˜, M(x) > M∗. Thus E˜ is not an invariant subset
and the trajectories starting there will leave this set as M(x) decreases till it reaches the
value M∗. But when this happens, the trajectories enter ΩM∗ and remain there as this is
an invariant set. This proves that the trajectories converge to ΩM∗ .
Chapter 2
A particular case: Neuromuscular
blockade (NMB) control
In this chapter, we present a particular case of compartmental systems: the neu-
romuscular blockade control (see, for instance, [Lemos et al (1991)],[Linkens(1994)] and
[Mendonça and Lago (1998)]). A complete description of this three-compartmental model
is made and some previous work concerning the control of this kind of systems is presented.
2.1 Neuromuscular blockade model
For surgery purposes, and in order to disable muscle contraction, a muscle relaxant
or neuromuscular blocker is usually administered to the patient undergoing general anes-
thesia. One of these muscle relaxants is atracurium. In the case of an intravenous ad-
ministration of this drug, the dynamic response of the neuromuscular blockade may be
modeled as proposed in [Mendonça and Lago (1998)], where the drug infusion rate u(t)
[µg kg−1min−1] is related with the effect concentration ce(t)[µgml−1] through a linear
dynamic pharmacokinetic-pharmacodynamic (PK/PD) model, describing the absorption,
distribution, metabolism and elimination of the drug by the body as well as its physiolog-
ical effects and the relationship between the drug concentration and effect. This model,
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obtained from real data, is given by
z˙1(t)
z˙2(t)
c˙e(t)
 =

−λ1 0 0
0 −λ2 0
q3 q3 −q3


z1(t)
z2(t)
ce(t)
+

a1
a2
0
u(t), (2.1.1)
where z1(t), z2(t), ce(t) are state variables and ai [kg ml−1],λi [min−1], i = 1, 2 and q3 [min−1]
are patient-dependent parameters. The neuromuscular blockade level r(t) is normalized be-
tween 0% and 100%, 0% corresponding to full paralysis and 100% to full muscular activity
(a description of the measurement process can be found for instance in [Kalli (2002)]), and
the relation between the effect concentration ce(t) and the neuromuscular blockade level
r(t) (%) is given by Hill equation (see [Magalhães et al (2005)] or [Weatherley et al (1983)],
for instance)
r(t) = 100C
γ
50
(ce(t))γ + Cγ50
, (2.1.2)
where C50 [µgml−1] and γ (dimensionless) are also patient dependent parameters.
The model (2.1.1) does not exhibit a compartmental structure. In order to apply the
theory of compartmental systems, we alternatively model the control of the administra-
tion of the neuromuscular relaxant drug atracurium to patients undergoing surgery as a
three compartmental model (a two-compartment pharmacokinetic model combined with
an effect compartment to model pharmacodynamics) that can be described as depicted in
Fig. 2.1, where u is the drug infusion dose administered in the central compartment, and
k12, k21, k13, q1, q2, q3 are positive micro-rate constants that vary from patient to patient
(see [Magalhães et al (2005)]). In this case, the set of equations ( 1.1.1) becomes
x˙1 = −(k12 + k13 + q1)x1 + k21x2 + u
x˙2 = k12x1 − (k21 + q2)x2
x˙3 = k13x1 − q3x3
(2.1.3)
and (1.1.2) becomes
x˙1(t)
x˙2(t)
x˙3(t)
 =

− (k12 + k13 + q1) k21 0
k12 − (k21 + q2) 0
k13 0 −q3


x1(t)
x2(t)
x3(t)
+

1
0
0
u(t), (2.1.4)
where x1, x2 and x3 are the drug amounts in the central, peripheral and effect com-
partments, respectively. The drug effect is given by ce = x3.
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Figure 2.1: Compartmental model for the effect of drug administration.
In [Magalhães et al (2005)], the control law (1.3.3) was applied for the target control of
the neuromuscular blockade level of patients undergoing surgery, by means of the infusion
of atracurium. Indeed, the following result was proved.
Theorem 2.1.1. For a suitable choice of M∗, the application of the control law (1.3.3) to
a system of the form (2.1.3) not only leads the mass to a certain value M∗, but also leads
the whole system state to an equilibrium point
x∗ = [x∗1 x∗2 x∗3]
T
where the third component, that corresponds to the neuromuscular blockade effect, is given
by x∗3 = crefe .
In [Magalhães et al (2005)] this theorem was proved. However, in order to keep this
thesis as much as possible self-contained, we present the given proof.
Proof. We already know that the application of (1.3.3) to this system leads the system
mass to a positive constant valueM∗ (see Theorem 1.3.1). Therefore, it is possible to show
that u˜(x) becomes nonnegative after a certain instant of time. Indeed, consider ε > 0.
Since M(x)→M∗,
∃t1 > 0 : ∀t ≥ t1,M(x) ∈ [M∗ − ε,M∗ + ε].
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Thus, for t ≥ t1, if we consider qmin = min {q1, q2, q3},
u˜(x) ≥ qminM(x) + λ (M∗ −M(x))
≥ qmin (M∗ − ε) + λ (M∗ − (M∗ + ε))
= qminM∗ − qminε− λε
= qminM∗ − ε (qmin + λ)
Note that
qminM
∗ − ε (qmin + λ) ≥ 0⇔ ε ≤ qminM∗qmin+λ .
Thus, if t1 is such that, for t ≥ t1, ε ≤ qminM∗qmin+λ , we prove that u˜(x) ≥ 0 from that instant
on.
In the following we will consider t ≥ t1.
We want to prove that x(t)→ x∗, where x∗ is such thatM(x∗) = M∗ and Ax∗+bu(x∗) = 0.
Considering this two equations, it is easy to verify that there is only one point that verifies
both and that point is:
x∗ = [α1x∗3 α2x∗3 x∗3]
T ,
where
α1 = q3k13 ,
α2 = α1 k12(k21+q2)
and
x∗3 = M
∗
1+α1+α2 .
Moreover,
˙︷ ︸︸ ︷
(x(t)− x∗) = Ax(t) + bu− (A+ b [q1 q2 q3])x∗
= Ax(t) + b [[q1 q2 q3]x(t) + λ [1 1 1] (x∗ − x(t))]−
− (A+ b [q1 q2 q3])x∗
= (A+ b [q1 q2 q3]− bλ [1 1 1]) (x(t)− x∗)
= A∗ (x− x∗) (t).
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It can be easily seen (using the Routh - Hurwitz stability criterion1) that all the eigen-
values of A∗ lie in ℂ-. Indeed, considering the matrix −A∗, it is easy to verify that
E1(−A∗) = λ+ q2 + q3 + k12 + k21 + k13
E2(−A∗) = (q3 + k13)(λ+ k21 + q2) + λ(k21 + q2 + k12) + q3k12
and
E3(−A∗) = λ [(q3 + k13)(k21 + q2) + q3k12].
Therefore, the first principal minors of Ω(−A∗) are
E1, E1E2 − E3 and E3 (E1E2 − E3)
and, since k12, k21, k13, q1, q2, q3 are positive micro-rate constants and λ is a positive design
parameter, it turns out that E1 > 0, E3 > 0 and
E1E2 − E3 = (λ+ q2 + q3 + k12 + k21 + k13) [(q3 + k13)(λ+ k21 + q2)+
+λ(k21 + q2 + k12) + q3k12]− λ [(q3 + k13)(k21 + q2) + q3k12]
= λλ(q3 + k13 + k21 + q2 + k12) + (q2 + q3 + k12 + k21 + k13)
[(q3 + k13)(λ+ k21 + q2) + λ(k21 + q2 + k12) + q3k12]
> 0
Thus, A∗ is stable and hence (x− x∗) (t)→ 0 or, equivalently, x(t)→ x∗.
Therefore, if
M∗ = crefe (1 + α1 + α2), (2.1.5)
1Let A be a square matrix of dimension 3, let Ek(A), k = 1, 2, 3 be the sum of all the principal minors
of A (a principal minor of A is the determinant of a smaller square matrix, cut down from A by removing
one or more of its rows and the corresponding columns) with order k and consider the following matrix,
called Routh-Hurwitz matrix:
Ω(A) =

E1(A) E3(A) 0
1 E2(A) 0
0 E1(A) E3(A)

It follows from Routh - Hurwitz stability criterion that all the eigenvalues of −A have negative real parts
if the first principal minors of Ω(A) (a first principal minor is the determinant of the sub-matrices in the
upper left corner, that is, the submatrices obtained by deleting the last rows and the corresponding last
columns of A) are positive (see [Horn and Johnson (1991)]).
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we have:
x(t)→ x∗,
with
x∗3 = M
∗
1+α1+α2 =
crefe (1+α1+α2)
1+α1+α2 = c
ref
e .
Although in [Magalhães et al (2005)] the convergence of the whole system state to an
equilibrium point was proved, even after a satisfactory identification of the patient’s char-
acteristics, it was necessary to consider an additional integrator, in order to achieve good
results. This might be explained by the fact that (contrary to what happens, for instance,
with state feedback stabilizers, which are not uniquely defined from the system matrices)
the control law (1.3.3) strongly depends on the system parameters. Since parameter un-
certainty is present not only in this case, but in most of the applications, it is relevant to
analyze the robustness of that control law.
Chapter 3
Total mass control of uncertain
compartmental systems
In this chapter, we analyze the total mass target control problem for compartmental
systems under the presence of parameters uncertainties. We consider the state feedback
control law (1.3.3) with positivity constraints tuned for a nominal system, and prove that
this law leads the value of the total mass of the real system to an interval whose bounds
depend on the parameter uncertainties and can be made arbitrarily closed to the desired
value of the total mass when the uncertainties are sufficiently small. In the final section of
this chapter, we present several simulations that illustrate our results.
3.1 Uncertain compartmental systems
In most of the applications, it is impossible to precisely know all the system parameters.
Therefore, in practice, we will be considering a nominal system
x˙ = (A+ ∆A)x+ bu, (3.1.1)
while the real system is given by
x˙ = Ax+ bu, (3.1.2)
being ∆A the matrix of parameter uncertainties. Thus, when we apply a control law (1.3.3)
to the real system, we will be applying a control law that was designed for the nominal
system instead. Note that :
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• since the control law (1.3.3) does not depend on the interactions between compart-
ments (that is, it does not depend on the kij’s) and assuming that it is possible to
precisely measure what is injected from the outside into the system (that is, the pa-
rameters bi are not subject to uncertainties 1), we shall consider the case where the
only uncertain parameters are q1, . . . , qn. Therefore, we shall assume that the matrix
∆A of parameter uncertainties is diagonal. Moreover we assume that the relative
error in the parameters is smaller than 100%, i.e., ∆qi = −∆aii is such that
|∆qi| ≤ qi, i = 1, ..., n;
• tuning the control law (1.3.3) for the nominal system yields
u(x) = max (0, u˜(x))
u˜(x) = (∑ni=1 bi)−1 (∑ni=1 (qi + ∆qi)xi + λ (M∗ −M(x))) ; (3.1.3)
• the results mentioned in Section 1.3 and in Section 2.1 hold if the control law that is
used to control a certain system is designed for that same system.
Therefore, it is relevant to analyze the convergence of the real system total mass under the
application of such a nominal control law.
3.2 Robustness
In this section we analyze the robustness of the control law (1.3.3) in the control of the
total system mass under the presence of parameter uncertainties. Indeed, we now prove
that, for suitable values of the design parameter λ, when the control law (3.1.3) is applied
to (3.1.2), the asymptotical values of the system mass lay in an interval which is related
to M∗ as stated in the next theorem ([Sousa et al (2007)] and [Sousa et al (2010)]).
1Although not a generic case, this is what happens in the application of neuromuscular blockade control
that we have in mind.
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Theorem 3.2.1. Let (3.1.2) be a fully outflow connected compartmental system, ∆q =
max {|∆qi|} and take the design parameter λ in (3.1.3) larger than ∆q. Then, the state
trajectories x(t) of the closed loop system (3.1.2)-(3.1.3), with arbitrary initial conditions
x(0) ∈ ℝn+, converge to the invariant set
Ω =
{
x ∈ ℝn+ : M(x) ∈ I(M∗)
}
,
with
I(M∗) =
[
λ
λ+ ∆qM
∗,
λ
λ−∆qM
∗
]
.
Proof. Let Mmin = λλ+∆qM
∗ and Mmax = λλ−∆qM
∗. Consider the function V : ℝn → ℝ
defined by
V (x) =

1
2
(
M(x)−Mmin
)2
if M(x) < Mmin
1
2
(
M(x)−Mmax
)2
if M(x) > Mmax
0 otherwise.
Note that V is a LaSalle-Lyapunov function of the system on ℝn+ because it is continuous
and V˙ (x) ≤ 0,∀x ∈ ℝn+ (see Definition 1.1.1). In fact, if x ∈ ℝn+,
V˙ (x) =

(
M(x)−Mmin
)
dM(x)
dt
if M(x) < Mmin(
M(x)−Mmax
)
dM(x)
dt
if M(x) > Mmax
0 otherwise
is non positive, as we next show.
• Suppose that M(x) < Mmin. Since
∑
n
i=1 (qi + ∆qi)xi + λ (M∗ −M(x)) ≥
∑
n
i=1 qixi −∆qM(x) + λ (M∗ −M(x))
= ∑ni=1 qixi + (λ+ ∆q) (Mmin −M(x))
> 0,
it follows that u˜(x) > 0. Thus,
u(x) = u˜(x) =
(
n∑
i=1
bi
)−1 ( n∑
i=1
(qi + ∆qi)xi + λ (M∗ −M(x))
)
.
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In this case,
dM(x)
dt
= ∑ni=1 ∆qixi + λ (M∗ −M(x)) ≥ −∆qM(x) + λ (M∗ −M(x))
= (λ+ ∆q)
(
Mmin −M(x)
)
> 0
and
V˙ (x) =
(
M(x)−Mmin
) dM(x)
dt
< 0.
• Suppose that M(x) > Mmax. If u˜(x) < 0, u(x) = 0 and
dM(x)
dt
= −∑ni=1 qixi ≤ 0.
Thus, in this case,
V˙ (x) =
(
M(x)−Mmax
) dM(x)
dt
≤ 0.
If u˜(x) ≥ 0, since u(x) = u˜(x), it follows that
dM(x)
dt
= ∑ni=1 ∆qixi + λ (M∗ −M(x)) ≤ ∆qM(x) + λ (M∗ −M(x))
= (λ−∆q)
(
Mmax −M(x)
)
< 0
and
V˙ (x) =
(
M(x)−Mmax
) dM(x)
dt
< 0.
Applying LaSalle’s invariance principle (see Theorem 1.1.5), we conclude that x(t)
converges to the largest invariant set contained in
{
x ∈ ℝn+ : V˙ (x) = 0
}
= I1 ∪ I2,
where
I1 =
{
x ∈ ℝn+ : M(x) ∈ I(M∗)
}
and
I2 =
{
x ∈ ℝn+ : u(x) = 0,
n∑
i=1
qixi = 0 and M(x) > Mmax
}
.
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It can be shown that the set I2 has no invariant subset. Indeed, if this would be the
case, u would be zero and the assumption of full outflow connectedness would imply that
M(x) → 0, meaning that x would leave the subset (see property iii) of compartmental
systems in Section 1.1). On the other hand, I1 is an invariant set (because it can be easily
proved that, if M(x) = Mmin, then dM(x)dt ≥ 0 and, if M(x) = Mmax, then dM(x)dt ≤ 0),
which concludes the proof of the theorem.
Remark 3.2.2.
i) The set I(M∗) is a neighborhood of M∗. This bounds the absolute mass offset by
max
{
M∗ − λ
λ+ ∆qM
∗,
λ
λ−∆qM
∗ −M∗
}
= ∆q
λ−∆qM
∗,
leading to the bound
∆q
λ−∆q
for the relative mass offset. Clearly, this bound tends to zero when ∆q goes to zero;
this means that the control law is robust with respect to parameter uncertainty. More-
over, increasing the parameter λ contributes to increasing the robustness of the control
law.
ii) When ∆qi = 0, i = 1, . . . , n, we recover the result stated in Theorem 1.3.1.
iii) Using the same kind of techniques as in Theorem 3.2.1, it is possible to show that,
under the same conditions, the state trajectories x(t) of the closed loop system (3.1.2)-
(3.1.3), with arbitrary initial conditions x(0) ∈ ℝn+, converge to the invariant set
Ω˜ =
{
x ∈ ℝn+ : M(x) ∈ I˜(M∗)
}
,
where
I˜(M∗) =
[
λ
λ−∆qminM
∗, λ
λ−∆qmaxM
∗
]
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and ∆qmin = min {∆qi}, ∆qmax = max {∆qi}, if the design parameter λ is larger
than ∆qmax.
This allows us to conclude that, in particular, if
∆q1 = ∆q2 = . . . = ∆qn = ∆,
since ∆qmin = ∆qmax = ∆, the state trajectory x(t) converges to the iso-mass ΩM ,
with
M = λ
λ−∆M
∗.
iv) Other bounds for the relative mass offset can be derived from set I˜(M∗), namely
max
{ |∆qmin|
λ−∆qmin ,
|∆qmax|
λ−∆qmax
}
.
3.3 Simulations
In this section, some simulation examples are presented for the control of the admin-
istration of the neuromuscular relaxant drug atracurium to patients undergoing surgery.
We consider that the patient’s real model is given by (2.1.3), with the following values for
the parameters, obtained from the simulated data base in [Alonso et al (2008-2)], (units
= min−1): k12 = 4.3157, k13 = 0.0017, k21 = 15.1814, q1 = 0.1047, q2 = 0.1, q3 = 0.0836.
We consider both the noiseless case and the case where the output (i.e., the third compo-
nent of the state) is corrupted by noise, which is assumed to have a log-normal distribution
with zero mean and variance equal to 0.1. Our aim is to stabilize the system mass on the
value M∗ = 72.0513 (which, in an exact modeling situation, can be shown (using 2.1.2 and
2.1.5) to correspond to the typical 10% level of neuromuscular blockade), using the control
law (3.1.3). Here we assume that all the state components are available for measurement.
We start by taking the design parameter λ = 0.2. In the first simulation, depicted in
Fig. 3.1, it is assumed that the nominal patient model coincides with the real one, i.e.,
∆qi = 0, i = 1, 2, 3. As expected, the system mass converges to M∗. Figure 3.2 shows
3.3 Simulations 23
the result of a simulation scenario, where the ∆qi’s are taken to be all equal, namely
∆q1 = ∆q2 = ∆q3 = 0.03. In this case, illustrating Remark 3.2.2 iii), the system mass
reaches the set-point M = λ
λ−∆M
∗ = 84.7662. The simulations in Fig. 3.3 and in Fig. 3.4
correspond to the case where the ∆qi’s are different. Finally, Fig. 3.5 and Fig. 3.6 illustrate
the behavior of the mass of the controlled system for different values of the parameter λ,
under fixed uncertainties for the system parameters. In accordance with our theoretical
results, one observes that the increasing of λ corresponds to the decrease of the final mass
offset. These simulations suggest that, up to the presence of noise, the asymptotical values
of the drug mass reach a constant value within the range which is expected according to
Theorem 3.2.1. This issue will be investigated in the next chapter.
(a)
(b)
Figure 3.1: Simulations for the neuromuscular blockade control. (a) Total system mass (left)
and drug dose (right), considering ∆qi = 0, i = 1, 2, 3. (b) Total system mass (left) and drug dose
(right), considering ∆qi = 0, i = 1, 2, 3, when the presence of noise is assumed.
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(a)
(b)
Figure 3.2: Simulations for the neuromuscular blockade control. (a) Total system mass (left)
and drug dose (right), considering ∆qi = 0.03, i = 1, 2, 3. (b) Total system mass (left) and drug
dose (right), considering ∆qi = 0.03, i = 1, 2, 3, when the presence of noise is assumed.
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(a)
(b)
(c)
Figure 3.3: Simulations for the neuromuscular blockade control. (a) Total system mass (left) and
drug dose (right) when ∆q1 = 0.02,∆q2 = 0 and ∆q3 = 0.05; the system mass lays asymptotically
in the interval I(M∗) = [57.6410, 96.0684]. (b) Total system mass (left) and drug dose (right)
when ∆q1 = −0.01,∆q2 = −0.04 and ∆q3 = −0.02; the system mass lays asymptotically in the
interval I(M∗) = [60.0427, 90.0641]. (c) Total system mass (left) and drug dose (right) when
∆q1 = 0.06,∆q2 = 0.01 and ∆q3 = −0.01; the system mass lays asymptotically in the interval
I(M∗) = [55.4241, 102.9304].
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(a)
(b)
(c)
Figure 3.4: Simulations for the neuromuscular blockade control when the presence of noise is
assumed. These simulations where obtained considering the same ∆qi’s as in the simulations in
Fig. 3.3.
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(a)
(b)
Figure 3.5: Simulations for the neuromuscular blockade control. These simulations where ob-
tained considering ∆q1 = −0.02,∆q2 = 0 and ∆q3 = −0.01, and different values of λ. (a) Total
system mass (left) and drug dose (right) for λ = 0.2. (b) Total system mass (left) and drug dose
(right) for λ = 2.
(a)
(b)
Figure 3.6: Simulations for the neuromuscular blockade control when the presence of noise is
assumed. These simulations where obtained considering the same ∆qi’s and the same λ’s as in
the simulations in Fig. 3.5.

Chapter 4
Neuromuscular blockade control
under uncertainty
In the final section of the previous chapter, the presented simulations suggest that, up
to the presence of noise, the application of the control law (3.1.3) to (2.1.3) not only leads
the total system mass to an interval whose bounds depend on the system parameters un-
certainties, but also leads it to a constant value within the aforementioned interval. In this
chapter, we shall give a theoretical explanation for the observed convergence. Moreover,
for a class of compartmental systems in ℝ3 of interest, and taking into account the rela-
tionship between the mass and the state components in steady state, the proposed mass
control law will be used to track desired values for the steady state components, which, in
particular, will allow to control the neuromuscular blockade level of patients undergoing
surgery, by means of the infusion of atracurium. Finally, concerning the control of such
level, a combination of several methodologies that, together, allow to improve the observed
results will be presented. Our results will be illustrated by several simulations and a real
case.
4.1 State convergence
It is proved in [Magalhães et al (2005)] that, in the absence of uncertainties, the appli-
cation of the control law (1.3.3) to a system of the form (2.1.3) not only leads the total
mass of the system to a certain value M∗, but also leads the whole system state to an
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equilibrium point x∗ (see Section 2.1). Here, we shall prove that a similar result still holds
under the presence of uncertainties. More concretely, under certain conditions, the nominal
control law under consideration leads the state of the real system to an equilibrium point
x¯ and consequently its total mass to a constant value M which are respectively related to
the equilibrium state x∗ and the desired mass value M∗ ([Sousa et al (2008)]). As we shall
later see, the convergence to a specific state equilibrium point is an important property in
the context of the control of the neuromuscular blockade level. Although we focus on the
administration of a muscular relaxant, our results are also valid for other compartmental
systems with the same structure.
In the following, ∆q = max {|∆qi|}, ∆qmin = min {∆qi}, ∆qmax = max {∆qi}, qmin =
min {qi} and qmax = max {qi}.
Recall that we may model the control of the administration of the neuromuscular re-
laxant drug atracurium to patients undergoing surgery as a three compartmental model.
In this case, the real system is given by
x˙1(t)
x˙2(t)
x˙3(t)
 =

− (k12 + k13 + q1) k21 0
k12 − (k21 + q2) 0
k13 0 −q3


x1(t)
x2(t)
x3(t)
+

1
0
0
u(t), (4.1.1)
and the control law to be applied to the real system is
u(x) = max (0, u˜(x))
u˜(x) = (∑ni=1 bi)−1 (∑ni=1 (qi + ∆qi)xi + λ (M∗ −M(x))) . (4.1.2)
The next proposition is useful to prove our main result.
Proposition 4.1.1. Assume that qmin + ∆qmin > ∆q and take the design parameter λ in
(4.1.2) larger than qmax + ∆qmax. Then, when the control law (4.1.2) is applied to ( 4.1.1),
there exists an instant t1 > 0 such that, for t ≥ t1,
u(x(t)) = u˜(x(t)) ≥ 0,
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Proof. According to Theorem 3.2.1, when the control law ( 4.1.2) is applied to (4.1.1), the
asymptotical values of the system mass lay in the interval
I(M∗) =
[
λ
λ+∆qM
∗, λ
λ−∆qM
∗
]
,
provided that the design parameter λ in (4.1.2) is larger than ∆q. This implies that, for
every ε > 0, there exists an instant tε > 0 such that
M(x(t)) ∈
[
λ
λ+ ∆qM
∗ − ε, λ
λ−∆qM
∗ + ε
]
,
for t ≥ tε. Note that
u˜(x) ≥ 0 ⇔ ∑3i=1 (qi + ∆qi)xi + λ (M∗ −M(x)) ≥ 0
⇔ ∑3i=1 (λ− qi −∆qi)xi ≤ λM∗.
Since λ > qmax + ∆qmax, it follows that λ− qmin −∆qmin > 0. Thus, for t ≥ tε,
3∑
i=1
(λ− qi −∆qi)xi(t) ≤ (λ− qmin −∆qmin)
(
λ
λ−∆qM
∗ + ε
)
,
and
(λ− qmin −∆qmin)
(
λ
λ−∆qM
∗ + ε
)
≤ λM∗ ⇔ ε ≤ λ
λ−qmin−∆qminM
∗ − λ
λ−∆qM
∗.
Since qmin + ∆qmin > ∆q and λ > qmax + ∆qmax, it is easy to show that
λ
λ−qmin−∆qminM
∗ − λ
λ−∆qM
∗ > 0.
Thus, if we take
ε = λ
λ−qmin−∆qminM
∗ − λ
λ−∆qM
∗
and t1 = tε, then u˜(x(t)) ≥ 0, for t ≥ t1.
Remark 4.1.2. Note that, although the previous proof is made for a three-compartmental
model, Proposition 4.1.1 is easily generalized to a compartmental system with n compart-
ments.
Let b in equation (3.1.1) be given by b = [1 0 0]T and consider the following point:
x¯ = [α1x¯3 α2x¯3 x¯3]T ,
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where
α1 = q3k13
α2 = q3k12(q2+k21)k13
x¯3 = λM
∗
(λ−∆q1)α1+(λ−∆q2)α2+(λ−∆q3) .
Proposition 4.1.3. If qmin + ∆qmin > ∆q and the design parameter λ in (4.1.2) is larger
than qmax + ∆qmax, then x¯ is the only equilibrium point of the closed loop system ( 4.1.1)-
(4.1.2) that belongs to the set
{
x ∈ ℝ3+ : dM(x)dt = 0
}
.
Proof. According to Proposition 4.1.1, there exists an instant t1 > 0 such that, for t ≥ t1,
u(x(t)) = u˜(x(t)) ≥ 0. Thus, for t ≥ t1,
dM(x(t))
dt
= 0 ⇔ ∑3i=1 ∆qixi(t) + λ (M∗ −M(x(t))) = 0
⇔ (λ−∆q1)x1(t) + (λ−∆q2)x2(t) + (λ−∆q3)x3(t) = λM∗
and the equilibrium points of the controlled closed-loop system ( 4.1.1)-(4.1.2) that belong
to the set {
x ∈ ℝ3+ : dM(x)dt = 0
}
are the solutions of the system  Ax+ bu = 0dM(x)
dt
= 0
. (4.1.3)
But, in this case,
u(x) = u˜(x) = (∑3i=1 bi)−1 (∑3i=1 (qi + ∆qi)xi + λ (M∗ −M(x)))
= ∑3i=1 qixi
= [q1 q2 q3]x,
thus, (4.1.3) becomes (A+ b [q1 q2 q3])x = 0(λ−∆q1)x1(t) + (λ−∆q2)x2(t) + (λ−∆q3)x3(t) = λM∗ .
and it is easy to verify that x is the only solution of this system.
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Theorem 4.1.4. Assume that qmin + ∆qmin > ∆q and take the design parameter λ in
(4.1.2) larger than qmax+∆qmax. Then, the state trajectories x(t) of the closed loop system
(4.1.1)-(4.1.2), with arbitrary initial conditions x(0) ∈ ℝ3+, converge to the equilibrium
point x.
Corollary 4.1.5. Under the same conditions of the previous result, the system mass con-
verges to the total mass M of the system in x¯, that is, to:
M = (α1+α2+1)λM∗(λ−∆q1)α1+(λ−∆q2)α2+(λ−∆q3) .
In the following, we prove Theorem 4.1.4.
Proof. Let x¯ be the equilibrium point mentioned in Proposition 4.1.3 and
M = (α1+α2+1)λM∗(λ−∆q1)α1+(λ−∆q2)α2+(λ−∆q3)
be the total mass of the system in x¯.
Take t1 > 0 such that, for t ≥ t1, u(x(t)) = u˜(x(t)) ≥ 0 (the existence of such an instant
is guaranteed by Proposition 4.1.1). Taking into account that
M∗ = (λ−∆q1)α1+(λ−∆q2)α2+(λ−∆q3)(α1+α2+1)λ M
= M − ∆q1α1+∆q2α2+∆q3(α1+α2+1)λ M,
for t ≥ t1 we have:
u(x(t)) = u˜(x(t)) = ∑3i=1 (qi + ∆qi)xi(t) + λ (M∗ −M(x(t)))
= ∑3i=1 qixi(t) +∑3i=1 ∆qi (xi(t)− x¯i) + λ (M −M(x(t)))
= [q1 q2 q3]x(t) + [∆q1 ∆q2 ∆q3] (x(t)− x¯) + λ [1 1 1] (x¯− x(t))
and
.︷ ︸︸ ︷
(x(t)− x¯) = Ax(t) + bu− (A+ b [q1 q2 q3]) x¯
= Ax(t) + b [[q1 q2 q3]x(t) + [∆q1 ∆q2 ∆q3] (x(t)− x¯) + λ [1 1 1] (x¯− x(t))]−
− (A+ b [q1 q2 q3]) x¯
= (A+ b [q1 q2 q3] + b [∆q1 ∆q2 ∆q3]− bλ [1 1 1]) (x(t)− x¯)
= A¯ (x− x¯) (t).
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Since it can be easily seen (using the Routh - Hurwitz stability criterion (see footnote
on page 15) that, for λ > qmax + ∆qmax, all the eigenvalues of A¯ lie in ℂ-, it turns out that
A¯ is stable and hence (x− x¯) (t)→ 0 or, equivalently,
x(t)→ x¯.
4.2 Convergence improvement
Assuming that the conditions of Theorem 4.1.4 are satisfied, the application of the
nominal control law to the system (4.1.1) makes the system mass converge to a constant
positive value
M = (α1 + α2 + 1)λM
∗
(λ−∆q1)α1 + (λ−∆q2)α2 + (λ−∆q3) , (4.2.1)
that may be different from M∗. In case the system mass reaches the value (4.2.1) in a
finite time t∗, this value will be known from that time instant on. This fact can be used
in order to redesign the controller and achieve convergence of the mass to the value M∗.
Indeed, if for t ≥ t∗, the new control law
u(x) = max (0, u˜(x))
u˜(x) = ∑3i=1 (qi + ∆qi)xi + λ (K −M(x)) , (4.2.2)
with K = (M∗)
2
M
, is applied, the system mass converges to M∗, because, in this case, (4.2.1)
becomes
(α1+α2+1)λK
(λ−∆q1)α1+(λ−∆q2)α2+(λ−∆q3) =
(α1+α2+1)λ
(M∗)2
M
(λ−∆q1)α1+(λ−∆q2)α2+(λ−∆q3)
= M∗.
If the system mass does not reach the value (4.2.1) in a finite time, it will not be possible
to follow the previous procedure. Nevertheless it is still possible to adapt our control law,
in order to guarantee that the asymptotical mass will be closer to the desired value, by
replacing M by M˜ = M(t), with t large enough to ensure that M˜ is close to M . Thus, if
the control law
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u(x) = max (0, u˜(x))
u˜(x) = ∑3i=1 (qi + ∆qi)xi + λ (L−M(x)) ,
with L = (M∗)
2
M˜
, is applied, Corollary 4.1.5 guarantees that, in this case, the total system
mass converges to
(α1 + α2 + 1)λ (M
∗)2
M˜
(λ−∆q1)α1 + (λ−∆q2)α2 + (λ−∆q3)
and, since M˜ ≈M , we have
(α1 + α2 + 1)λ (M
∗)2
M˜
(λ−∆q1)α1 + (λ−∆q2)α2 + (λ−∆q3) ≈M
∗.
In the sequel, some simulation examples are presented for the control of the admin-
istration of the neuromuscular relaxant drug atracurium to patients undergoing surgery.
The values of the parameters are exactly the same as in Section 3.3 and, similarly to what
has been done in that section, we shall consider both the noiseless case and the case where
the output is corrupted by noise. Our aim is to stabilize the system mass on the value
M∗ = 72.0513 and we start by taking the design parameter λ = 0.2. Figure 4.1 and Fig.
4.2 illustrate the behavior of the mass of the controlled system for this value of λ and
different values for ∆qi. Figure 4.3 and Fig. 4.4 illustrate the behavior of the mass of the
controlled system for different values of the parameter λ, under fixed uncertainties for the
system parameters. According to the previous study, when we change our control law the
system mass is brought near to the desired value M∗.
4.3 Control of the neuromuscular blockade level
In the absence of uncertainties (i.e., if ∆qi = 0, i = 1, 2, 3), it follows from Theorem
4.1.4 that, considering
M∗ = (α1 + α2 + 1) crefe ,
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(a)
(b)
Figure 4.1: Simulations for the neuromuscular blockade control. (a) Total system mass (left)
and drug dose (right) when ∆qi = 0.03, i = 1, 2, 3. (b) Total system mass (left) and drug dose
(right) when ∆q1 = 0.02,∆q2 = 0 and ∆q3 = 0.05.
(a)
(b)
Figure 4.2: Simulations for the neuromuscular blockade control when the presence of noise is
assumed. These simulations where obtained considering the same ∆qi’s as in the simulations in
Fig. 4.1.
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(a)
(b)
Figure 4.3: Simulations for the neuromuscular blockade control. These simulations where ob-
tained considering ∆q1 = −0.02,∆q2 = 0 and ∆q3 = −0.01, and different values of λ. (a) Total
system mass (left) and drug dose (right) for λ = 0.2. (b) Total system mass (left) and drug dose
(right) for λ = 2.
(a)
(b)
Figure 4.4: Simulations for the neuromuscular blockade control when the presence of noise is
assumed. These simulations where obtained considering the same ∆qi’s and the same λ’s as in
the simulations in Fig. 4.3.
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the application of the control law (1.3.3) to (4.1.1) leads the system state to an equilibrium
point
xM
∗ =
[
xM
∗
1 x
M∗
2 x
M∗
3
]T
where the third component, that corresponds to the neuromuscular blockade effect, is
given by xM∗3 = crefe . Furthermore, the relation between the effect concentration ce and
the neuromuscular blockade level r(t) is given by Hill equation
r(t) = 100C
γ
50
(ce(t))γ + Cγ50
,
where C50 and γ are patient dependent parameters and, in order to obtain a set-point
r(t) = r∗, the corresponding effect concentration crefe is given by
crefe = C50
(100
r∗
− 1
)1/γ
.
This allows to conclude that it is possible to control the neuromuscular blockade level via
total mass control.
In the presence of uncertainties, a control law (4.1.2) for the nominal system is designed
considering
M∗ = (α1nominal + α2nominal + 1) crefe ,
where αinominal refers to the value of αi for the nominal system. Clearly, if this control
law were applied to the nominal system, we would be able to guarantee that the state
trajectories would converge to an equilibrium point whose third component would be equal
to the desired reference. However, according to Theorem 4.1.4, the application of this
control law to the real system will make the state trajectories converge to the equilibrium
point
x¯ = [α1x¯3 α2x¯3 x¯3]T ,
with
α1 = q3k13
α2 = q3k12q2k13+k21k13
x¯3 = λM
∗
(λ−∆q1)α1+(λ−∆q2)α2+(λ−∆q3) .
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Since M∗ = (α1nominal + α2nominal + 1) crefe , it follows that∣∣∣x¯3 − crefe ∣∣∣ = ∣∣∣∣ λ(α1nominal+α2nominal+1)crefe(λ−∆q1)α1+(λ−∆q2)α2+(λ−∆q3) − crefe
∣∣∣∣
= crefe
∣∣∣λ(α1nominal+α2nominal−α1−α2)+∆q1α1+∆q2α2+∆q3(λ−∆q1)α1+(λ−∆q2)α2+(λ−∆q3) ∣∣∣
and clearly x¯3 → crefe when the parameter uncertainties go to zero; moreover, increasing
the parameter λ contributes to increase the robustness of the control law.
4.4 Total Mass Control Infusion strategy
During a surgery that requires general anesthesia, the manual setting of the dose that
is needed provides satisfactory results, but the anesthetist has to make timely adjustments
to the infusion pump to ensure that the correct dose is maintained. Therefore, in order
to turn this control easier and safer, computerized systems have been developed. In these
cases, the anesthetist selects the required concentration of drug in the patient’s blood,
and the control system sets and adjusts the needed dose to achieve it. This process is
known as target controlled infusion (TCI) (for an overview of target controlled infusions
see, for instance, [Absalom and Struys (2007)]). Since the dose profile is predicted by
validated population models, these open-loop control devices do not compensate when the
models and the patient dynamics are too different and they are not completely adequate for
drug administration ([Ting et al (2004)]). Therefore we follow the strategies for real cases
assessment, defined by Teresa Mendonça and co-workers, based upon the best practices,
in order to overcome the clinical constraints, patient variability and noise measurements.
Namely, during the 10 first minutes the system should work on open loop and a dedicated
time varying reference profile should be used. Moreover, for real clinical cases, the reference
comprises a time varying transient phase until steady state is assumed to be achieved
(approximately at minute 75), after which a constant target value is assumed. Hence, a
new control strategy was proposed, taking into account the need for adaptation in TCI
(see [Silva et al (2009)]). This strategy includes an on line parameter estimation scheme
along with the total mass control for compartmental systems. It comprises an On line tuned
Algorithm for Recovery Detection (OLARD), applied after an initial bolus administration1,
1At the beginning of a surgery, in a phase known as the induction phase, a bolus of atracurium is
usually administered, i.e., a single dose injected over a short period of time with the purpose of inducing
40 4. Neuromuscular blockade control under uncertainty
and an iterative Bayesian identification method during the transient phase. At this stage,
a good estimation of the patient parameters is assumed to be obtained. To design the
drug dosage profile, two algorithms are proposed. Initially, an Input Variance Control
(IVC) algorithm is used. It is based on the concept of TCI and aims to take the drug
effect to the predefined target profile within an apriori defined interval of time, i.e., during
the transient phase. Afterwards, the drug dose regimen is controlled by the Total Mass
Control (TMC) algorithm, since the global theoretical conditions are assumed to be verified.
The mass control for compartmental systems was already shown to be robust even in
the presence of parameter uncertainties. The implementation of this control strategy is
here illustrated for the particular case of the closed-loop control of the neuromuscular
blockade level, by means of the infusion of atracurium. In order to cover a wide range of
behaviors, a bank of nonlinear dynamic modelsM = {Mi, i = 1, . . . , 100} was generated
(see [Alonso et al (2008-2)]).
4.4.1 PK/PD Bayesian Identification
Let Θ be a vector that incorporates the patient dependent parameters, that is,
Θ = [a1, λ1, a2, λ2, q3, C50, γ],
where a1, λ1, a2, λ2 and q3 are the parameters that appear in (2.1.1) and C50 and γ are
the parameters that appear in (2.1.2). According to this Bayesian approach, when a
measurement of the neuromuscular blockade level r(t) is available, the estimations of
the patient PK/PD parameters are actualized by minimizing the following Bayesian ob-
jective cost function, which assumes an underlying log-normal distribution for Θ (see
[Jannett and Aragula (1992)]):
a rapid decrease in the neuromuscular blockade level. The typical bolus is of 500µg kg−1 and, for control
purposes, while the bolus is acting, the value of the reference is fixed at a low level, being gradually raised
to the set-point r∗ (typically 10%) in order to avoid sudden changes, stabilizing on this value after minute
75 (steady-state) (see [Mendonça and Lago (1998)]).
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H(θˆ, u) =
m∑
j=1
(ln(θj)− ln(θˆj))2
σ2j
+ (4.4.1)
+
n∑
k=1
(ln(T (tk))− ln(T (tk;u, Θˆ))2
σ2k
where
• the vector Θ represents the PK/PD for some population model;
• Θˆ = [θˆ1, θˆ2, · · · , θˆm], (with m = 7, because for C50 the mean population value has
been used [Alonso et al (2008)]) stands for the individual patient identified parame-
terization;
• u(t) is the drug dose;
• T (tk) = ln r(tk)100−r(tk) = γ ln C50ce(tk) is a function of the NMB measured signal at time tk;
• T (tk;u, Θˆ) is the predicted at time tk induced by u(t) on the patient model with
parameter vector Θˆ;
• σ2j is the variance of the logarithmic distribution assumed for the population PK/PD
parameter θj;
• σ2k describes the variance of the error on the measurement of the individual NMB
signal at t = tk.
This identification procedure begins at the time instant given by the next algorithm.
4.4.2 The On Line tuned Algorithm for Recovery Detection
When the drug dose is automatically administrated, the time evolution of the measured
neuromuscular blockade level r(t) is highly dependent on the time instant t0 that is chosen
to start the continuous drug infusion u(t). Therefore, it is very important to consider an
on-line detection for that assumed initial recovery t0, which may be used as a decision flag,
alarm or advisory component in an automatic drug delivery setup. During the induction
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phase, the proposed algorithm (OLARD) (see [Sebastião et al (2009)]) initially computes
a detection baseline (reference profile) in order to overcome a variety of sensor drawbacks.
Thereafter, the detection of the NMB recovery from the initial bolus administration is
computed through an algorithm developed taking into account the baseline and the char-
acteristics of the signal under study. The algorithm parameters were tuned in simulation
(using the model bank M) and in real cases (previously collected during monitoring or
control procedures in patients undergoing surgery). However, in order to achieve a robust
and reliable performance, the algorithm parameters may be then adjusted on line, taking
into account the predicted degree of patient variability and the level of sensor noise, as
well as the clinical experience about the system environment.
4.4.3 Input Variance Control algorithm
Let t0 be the previously identified time for recovery and t1 be the instant time where
steady-state is supposed to be reached, that is, r(t1) = r∗. Then, the Input Variance
Control algorithm (IVC) controls the system in the transient phase [t0, t1], by designing
an optimal dose regimen profile for steering the NMB level from its value r(t0) at t0 to a
previously defined value r(t1) = r∗ at t1 (see [Silva et al (2009)]). During this process, the
patient neuromuscular blockade level r(t) is measured in each time instant, after applying
a certain dose u(t0) corresponding to the first value of the obtained optimal drug regimen.
Thereafter, inverting Hill equation (2.1.2), the corresponding effect concentration is calcu-
lated and a new target profile c∗e is considered. This procedure is then repeated, until the
end of the transient period.
4.4.4 Total-mass control algorithm
For practical purposes, the identification procedure is stopped as soon as the parame-
ters are assumed to be reasonably identified and the reference signal attains the previously
defined value r∗ = 10%. Therefore, in order to avoid computational burden, from this
time instant on the individual patient parameterization is assumed to be fixed (neverthe-
less, it is possible to on-line require supplementary identification procedure in order to
obtain a more accurate parameter estimation). From this point on, the control strategy
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is changed to a mass control scheme. For this purpose, the patient is modeled as a three-
compartmental system (see fig. 2.1), being the values of q1 and q3 as well as the initial
values of xi, i = 1, 2, 3, obtained from the previously estimated parameters and u(t) the
drug infusion dose given by the control law (1.3.3), where M∗ is the total amount of drug
in the three compartments, computed in such a way that yields the target value r∗ for
the neuromuscular blockade level (see Section (4.3)).The parameter q2 is assumed to be
approximately zero (see [Godfrey (1983)]). Since the parameters qi’s are affected by an
estimation error, this control law becomes (4.1.2) and a steady state error will occur. In-
deed, in Section 3.2 it is shown that, if ∆qi denotes the error of qi, when the drug infusion
dose is administered in the central compartment, the total amount of drug in the three
compartments will converge to a value that depends on ∆qi’s. Moreover, according to the
robustness analysis that was already made in that section, the decreasing of the values
∆qi, i = 1, 2, 3, corresponds to the decreasing of the steady state error. However, after the
beginning of this control scheme, ∆q1,∆q2 and ∆q3 are fixed. Therefore, in order to reduce
the steady state error, we redesign our control law, by replacing the original value of M∗
by another one, based on information about the obtained steady state error (see section
4.2).
4.4.5 Results
Simulations
In order to test the previously described strategy, simulation studies have been carried
out using the model bankM. Note that, after the typical bolus administration, the NMB
level decreases very quickly and full paralysis is induced in a few minutes. After the
induction phase, the control goal is to follow a certain reference that allows to reach a
desired target value.
Figures 4.5 and 4.6 illustrate the filtered NMB level, the target value and the adminis-
tered drug dose for patient M60 ∈ M after control with the Total Mass Control Infusion
strategy.
In Fig. 4.5, and in order to highlight the algorithm performance, the exact parame-
terization of the simulated patient (Θˆ = ΘM60) was assumed to be known and the NMB
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Figure 4.5: NMB level (upper plot) and drug dose (lower plot) for patient number 60 (Θˆ = Θ60)
inM, that result from the control with the Total Mass Control Infusion. The ’dot’ in the xx-axis
indicates the time instant t0 computed by OLARD. Note that NMB signal is the filtered NMB
simulated considering the presence of noise (σ = 0.3; 0).)
Figure 4.6: NMB level (upper plot) and drug dose (lower plot) for patient number 60 (Θˆ identified
with the Bayesian algorithm from t0 until t1) inM, that result from the control with the Total
Mass Control Infusion. The ’dot’ in the xx-axis indicates the time instant t0 computed by OLARD.
Note that NMB signal is the filtered NMB simulated considering the presence of noise (σ =
0.3; 0).)
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level is represented with a maximum value of 30% to illustrate the reference tracking in
detail. The dot indicates the estimated beginning of recovery according to OLARD, and
the instant time t0 is then used as the decision flag to enable the start of the atracurium
continuous infusion. After the t0 identification, the NMB level is driven, by IVC strategy,
from r(t0) to the target value r(t1 = 75min) = r∗ = 10% . Afterwards, the TMC is applied
to control the system by designing a control law that sustains the system total mass in the
value M∗, corresponding to r∗(t) = 10%. By analyzing Fig. 4.5 and 4.6, TMC strategy
had driven the NMB level to a value bellow 10%. This neglected constant steady state
error occurs since the existence of parameters uncertainties (∆qi 6= 0) has been considered.
For the case illustrated in Fig. 4.6, during the transient period [t0, t1], the patient
parameters were identified every 3 minutes by the identification Bayesian algorithm. Pa-
rameters evolution over time is shown in Fig. 4.7, being the values normalized by the
population values. Notice that, in order to use the TMC algorithm, the values of q1, q2 and
q3 are needed. However, only q1 and q3 are identified, since parameter q2 is assumed to be
approximately zero (see [Godfrey (1983)]).
Figure 4.7: Evolution of parameters q1 and q3, from minute 10 until t1 = 75min, corresponding
to the simulation represented in Fig. 4.6. Refinements of the parameterization were carried out
from t0 = 30min until t1. The values are normalized with the population parameter values (bank
of modelsM).
The NMB level r(t) presents an overshoot after the beginning of the continuous infusion,
which may be explained by the fact that the drug dose initially calculated through IVC al-
gorithm is based on initial ’rough’ parameter estimations. However, with the improvement
of the parameter estimations during the transient phase, the drug dose is updated accord-
ingly, driving the NMB value to the desired target. Afterwards, TMC strategy sustains
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Figure 4.8: Total mass evolution for model 60 (Θˆ). In solid line is represented the desired
total mass (M∗(Θˆfinal)); in dotted line is represented the theoretical value of M∗(Θ60) for this
simulated patient; in dashed line is represented the time evolution of the system total mass
(M(x)); in dots is represented the different values of M∗(Θˆk) in the transient phase)
the continuous infusion and brings the NMB level to a value near 8% (as already men-
tioned, this negleted constant steady state error occurs since the existence of parameters
uncertainties has been considered). Figure 4.8 represents the desired value for the total
mass of the system (solid line) and the time evolution of M(x), the current total mass (in
dashed line). In accordance with to the study presented in Section 4.2, at the time instant
indicated by the arrow the control law was redesigned, by replacing the original value of
M∗ by another one, based on information about the obtained steady state error. The total
mass convergence is then modified, being the total mass driven to the target value of M∗.
Clinical case
The Total Mass Control Infusion strategy was recently integrated in the software Hip-
pocrates ([Mendonça et al (2004)]) and it is under evaluation on patients undergoing gen-
eral anesthesia. Figure 4.9 illustrates the first case so far obtained on a patient undergoing
elective surgery. The clinical performance was considered satisfactory inspite of the steady-
state error observed during the control with the TMC algorithm. The filtered NMB level
indicates the presence of sensor noise superimposed on the measured signal. The estimated
recovery time according to OLARD specifications was considered correct by the clinician.
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Figure 4.9: Real NMB level (upper plot) and drug dose (lower plot) administered to the real
patient (Θˆ identified with the Bayesian algorithm from t0 until t1), that result from the control
with the Total Mass Control Infusion. The ’dot’ in the xx-axis indicates the time instant t0
computed by OLARD. Note that NMB signal is corrupted with sensor noise.)
Time parameter evolution is shown in Fig. 4.10, being the values normalized by the
population values. In accordance to the simulated case, the trajectory of the parameter q3
is smoother than the trajectory of q1.
Figure 4.10: Evolution of parameters q1 and q3, from minute 10 until t1 = 75min, corresponding
to the real control case represented in Fig. 4.9. Refinements of the parameterization were carried
out from t0 = 40min until t1. The values are normalized with the population parameter values
(bank of modelsM).
In Fig. 4.11 is represented the desired value for the total mass of the system (solid line)
and the time evolution of M(x), the current total mass (in dashed line). The total mass
convergence presents a similar behavior with the reported simulated cases.
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Figure 4.11: Total mass evolution for the real control case. In solid line is represented the
desired value for the total mass (M∗(Θˆfinal)); in dashed line is represented the time evolution
of the system total mass (M(x)); in dots is represented the different values of M∗(Θˆk) in the
transient phase.)
The steady-state error observed in Fig. 4.9 may be justified by the fact that this
particular real case does not present a standard behavior during the induction phase,
since the NMB level was supposed to reach 0%. As a matter of fact, the step behavior
observed during this phase, at an approximately constant value of 5%, is a phenomenon
that sometimes occurs and according to experient clinicians it is due to sensor drawbacks
or noise measurements. Moreover, the clinicians do not consider these cases adequate for
identification purposes. Nevertheless, the clinical performance was considered satisfactory.
Chapter 5
Observers
In the previous chapters we have assumed that all the state components were available
for measurement. However, this is not the case in practical applications. Therefore it
is necessary to obtain state estimates in order to perform control. In this chapter we
analyze the performance of state-observers in the control of compartmental systems under
the presence of uncertainties in the system initial state, but under the assumption that
the system parameters are accurate. The incorporation of parameter uncertainties is left
for future work. We combine a state feedback control law with positivity constraints and
a state observer and prove that the application of this combined control law leads the
total real system mass to a certain constant positive value. Moreover we show that, for a
class of three-compartmental systems of interest, the resulting mass control law also allows
reaching a desired steady state. Our results are illustrated by several simulations for the
control of the administration of a neuromuscular relaxant to patients undergoing surgery,
which show the relevance of incorporating an observer for convergence acceleration even in
case the original system is asymptotically stable.
5.1 A brief overview
In most practical cases, the physical state of a system cannot be determined by direct
observation. In these cases, we often use a state observer (see [Luenberger (1964)] and
[Luenberger (1966)], for instance) to estimate the state from the knowledge of the input
and the output of the real system. In this section, we analyze the effect of replacing the
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unknown state of the system by its estimate provided by an observer for control purposes.
Consider the SISO compartmental system described by
 x˙ = Ax+ buy = Cx (5.1.1)
where A is a n× n compartmental matrix, b = (b1, b2, . . . , bn)T (with bi nonnegative and
at least one bi positive), C = (c1, c2, . . . , cn) (with ci nonnegative) and let the closed-loop
state estimator Ω be described by

˙ˆx = (A− LC) xˆ+ bu+ Ly,
yˆ = Cxˆ
where xˆ is the estimated state and
L = (l1, l2, . . . , ln)T
is a vector of gains such that
σ(A− LC) ⊂ ℂ-.
Note that, in this thesis, we are only considering fully outflow connected systems (see
Section 1.1) and fully outflow connectedness of compartmental systems is equivalent to
asymptotical stability (see Section 1.2). According to [Kwakernaak and Sivan (1972)], if
the system (5.1.1) is asymptotically stable, then (C,A) is detectable1. Thus, the existence
of such L is guaranteed.
Consider the control law (1.3.3) and suppose that we take the estimated state xˆ instead of
the real state x. Then, the control law to be applied to (5.1.1) is:
u(xˆ) = max (0, u˜(xˆ))
u˜(xˆ) = (∑ni=1 bi)−1 (∑ni=1 qixˆi + λ (M∗ −M(xˆ))) . (5.1.2)
1The pair (C,A) is said to be detectable if there is a vector L such that σ(A − LC) ⊂ ℂ- (see
[Trentelman et al (2001)], for instance).
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Remark 5.1.1. The construction of positive observers is an important issue in the the-
ory of linear positive systems. For instance, in [Härdin and van Schuppen (2007)], the
synthesis of positive linear observers for linear positive systems is considered. However,
i) in this thesis the observer system is not required to be positive, since the control law u
is subject to a positivity constraint. Note moreover that this positivity constraint is
necessary even when the (positive) real state x is used instead of the estimate xˆ;
ii) the non-linearity of the considered control law (5.1.2) implies the non-linearity of our
controlled system;
iii) when the real system is linear, the certain equivalence principle holds, that is, applying
the control law given by the observer to the real system, the system state still converges
to the same equilibrium point as when the applied control law is the one given by the
real state. However, for non-linear systems that principle does not always hold.
In the sequel, we analyze the convergence of the state trajectories of the closed loop
system (5.1.1)-(5.1.2).
5.2 Total mass convergence
Theorem 5.2.1. ([Sousa et al (2009)]) Let (5.1.1) be a compartmental system such that
qi 6= 0, i = 1, . . . , n. Then, the state trajectories x(t) of the closed loop system (5.1.1)-
(5.1.2), with arbitrary initial conditions x(0) ∈ ℝn+, converge to the set
Ω =
{
x ∈ ℝn+ : M(x) = M∗
}
.
Remark 5.2.2. This theorem can be proved using the results in [Sontag (2003)]. However,
in order to keep this thesis as much as possible self-contained, we present an alternative
proof, using more elementary tools.
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Proof. Consider the control law (5.1.2). When this control law is applied to the real system,
we obtain:
x˙1 = Ax1 + bu (xˆ) . (5.2.1)
Our goal is to prove that M(x1) converges to M∗. Consider e(t) = xˆ(t)− x1(t). Then, the
control law (5.1.2) becomes
u(xˆ) = max (0, u˜(xˆ))
u˜(xˆ) = (∑ni=1 bi)−1 (∑ni=1 qi (x1i + ei) + λ (M∗ −M(x1 + e)))
= (∑ni=1 bi)−1 (∑ni=1 qix1i + λ (M∗ −M(x1, e)) + (∑ni=1 bi)−1∑ni=1 qiei,
where [e1 . . . en]T = e and M(x1, e) = M(x1) + M(e). Since e˙ = (A− LC)e and L is such
that σ(A− LC) ⊂ ℂ-,
e(t) = xˆ(t)− x1(t)→ 0,
that is,
xˆ(t)→ x1(t).
Therefore,
∀ε1 > 0 ∃t1 > 0 : ∀t > t1,−ε1 < ei(t) < ε1.
Consider ε1 > 0 and take t1 > 0 such that the previous condition is verified. Then, since
−
n∑
i=1
qiε1 <
n∑
i=1
qiei <
n∑
i=1
qiε1,
we have
u˜(xˆ) > (∑ni=1 bi)−1 (∑ni=1 qix1i + λ(M∗ − ∑ni=1 qiλ ε1 −M(x1, e)
))
and
u˜(xˆ) < (∑ni=1 bi)−1 (∑ni=1 qix1i + λ(M∗ + ∑ni=1 qiλ ε1 −M(x1, e)
))
.
In the following we take
M∗1 = M∗ −
∑n
i=1 qi
λ
ε1,
M∗2 = M∗ +
∑n
i=1 qi
λ
ε1
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and suppose that
∑
n
j=1 lj ≥ 0.
In this case, when u˜(xˆ) ≥ 0,
M˙(x1, e) = λ (M∗ −M(x1, e))−∑nj=1 lj∑ni=1 ciei
≤ λ (M∗ −M(x1, e)) +∑nj=1 lj∑ni=1 ciε1
= λ
(
M∗ +
∑n
j=1 lj
∑n
i=1 ci
λ
ε1 −M(x1, e)
)
and
M˙(x1, e) = λ (M∗ −M(x1, e))−∑nj=1 lj∑ni=1 ciei
≥ λ
(
M∗ −
∑n
j=1 lj
∑n
i=1 ci
λ
ε1 −M(x1, e)
)
.
Define
M1 = M∗ −
∑n
j=1 lj
∑n
i=1 ci
λ
ε1,
M2 = M∗ +
∑n
j=1 lj
∑n
i=1 ci
λ
ε1
and let M1 = min
{
M1,M
∗
1
}
and M2 = M2.
Consider the function V : ℝn+ × ℝn → ℝ defined by
V (x1, e) =

1
2 (M(x1, e)−M1)2 if M(x1, e) < M1
1
2 (M(x1, e)−M2)2 if M(x1, e) > M2
0 otherwise.
Note that V is a LaSalle-Lyapunov function of the system (5.2.1) in ℝn+×ℝn (see Definition
1.1.1) because it is continuous and
V˙ (x1, e) ≤ 0,∀(x1, e) ∈ ℝn+ × ℝn.
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In fact, if (x1, e) ∈ ℝn+ × ℝn,
V˙ (x1, e) =

(M(x1, e)−M1) M˙(x1, e) if M(x1, e) < M1
(M(x1, e)−M2) M˙(x1, e) if M(x1, e) > M2
0 otherwise
is non positive, as we next show.
• Suppose that M(x1, e) < M1. In this case, u˜(xˆ) and M˙(x1, e) will be positive if ε1 is
such that 
∑n
j=1 lj
∑n
i=1 ci
λ
ε1 < M
∗∑n
i=1 qi
λ
ε1 < M
∗
.
Since ε1 > 0 is arbitrary, we shall suppose that this is the case. Therefore,
V˙ (x1, e) = (M(x1, e)−M1) M˙(x1, e) < 0.
• Suppose that M(x1, e) > M2. In this case, if u˜(xˆ) ≥ 0, M˙(x1, e) < 0. If u˜(xˆ) < 0,
u(xˆ) = 0 and, if we define qmin = min {qi} ,
M˙(x1, e) = −∑ni=1 qix1i −∑ni=1 qiei −∑nj=1 lj∑ni=1 ciei
≤ −qminM(x1) +∑ni=1 qiε1 +∑nj=1 lj∑ni=1 ciε1
< −qminM2 + qminM(e) +∑ni=1 qiε1 +∑nj=1 lj∑ni=1 ciε1
< −qminM2 + nqminε1 +∑ni=1 qiε1 +∑nj=1 lj∑ni=1 ciε1.
Since qminM2 > 0, it is possible to choose ε1 > 0 such that
−qminM2 +
(
nqmin +
∑
n
i=1 qi +
∑
n
j=1 lj
∑
n
i=1 ci
)
ε1 < 0.
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Then, for t ≥ t1,
M˙(x1, e) < 0
and
V˙ (x1, e) = (M(x1, e)−M2) M˙(x1, e) < 0.
Applying LaSalle’s invariance principle (see Theorem 1.1.5), it turns out that (x1, e)(t)
converges to the largest invariant set contained in
{
(x1, e) ∈ ℝn+ × ℝn : V˙ (x1, e) = 0
}
=
{
(x1, e) ∈ ℝn+ × ℝn : M(x1, e) ∈ [M1,M2]
}
.
Then, M(x1, e)→ [M1,M2].
The case where ∑nj=1 lj < 0 is similar to the previous one.
Note that the definitions of M1 and M2 allow to conclude that there is a neighborhood
of M∗,
N = ]M∗ − ε,M∗ + ε[, with ε > 0,
such that N ⊃ [M1,M2] .
Indeed, if
ε = max

∣∣∣∑nj=1 lj∣∣∣∑ni=1 ci
λ
ε1,
∑
n
i=1 qi
λ
ε1
 ,
it is easy to verify the previous inclusion. Since ε1 can be taken as small as we want, we
prove that M(x1, e)→M∗. Thus, as M(e)→ 0, we prove that
M(x1)→M∗
as desired.
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5.3 Neuromuscular blockade case
In Section 2.1 it was proved that the application of the control law (1.3.3) to a system
of the form (4.1.1) not only leads the mass to a certain value M∗, but also leads the whole
system state to the unique steady state x∗ with mass M∗,
x∗ = [α1 α2 1]T M
∗
α1+α2+1 ,
where α1 and α2 depend on the micro-rate constants kij and qi. Here, we shall prove that
a similar result still holds when we control our system (4.1.1), using a control law (5.1.2)
([Sousa et al (2009)]). Although we focus on the administration of a muscular relaxant,
our results are also valid for other compartmental systems with the same structure. The
next proposition is useful to prove the main result of this section.
Proposition 5.3.1. Suppose that qi 6= 0, i = 1, ..., n. Then, when the control law (5.1.2)
is applied to (5.1.1), there exists an instant t1 > 0 such that, for t ≥ t1,
u(xˆ(t)) = u˜(xˆ(t)) ≥ 0,
Proof. According to Theorem 5.2.1, when the control law (5.1.2) is applied to (5.1.1), the
system mass converges to M∗. This implies that, for every ε > 0, there exists an instant
t1 > 0 such that
M(x) ∈ [M∗ − ε,M∗ + ε] ,
for t ≥ t1. Since e(t)→ 0, there is also a positive instant such that−ε < ei < ε, i = 1, . . . , n,
from that instant on. Suppose that t1 > 0 is such that the two previous conditions are
verified for t ≥ t1. Thus, for t ≥ t1,
u˜(xˆ) = (∑ni=1 bi)−1 (∑ni=1 qixi +∑ni=1 qiei + λ (M∗ −M(x)−M(e)))
≥ (∑ni=1 bi)−1 (qminM(x)−∑ni=1 qiε+ λM∗ − λ (M∗ + ε)− λnε)
≥ (∑ni=1 bi)−1 (qmin (M∗ − ε)−∑ni=1 qiε+ λM∗ − λ (M∗ + ε)− λnε)
= (∑ni=1 bi)−1 [qminM∗ − (qmin +∑ni=1 qi + λ(n+ 1)) ε]
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and, if ε ≤ qmin
qmin+
∑n
i=1 qi+λ(n+1)
M∗, it is easily seen that
u(xˆ(t)) = u˜(xˆ(t)) ≥ 0.
Proposition 5.3.2. Consider that qi 6= 0, i = 1, 2, 3. The state trajectories x(t) of the
closed loop system (4.1.1)-(5.1.2), with arbitrary initial conditions x(0) ∈ ℝ3+, converge to
x∗.
Proof. Define
F = [q1 − λ q2 − λ q3 − λ]
and v = λM∗.
According to Proposition 5.3.1, there exists an instant t1 > 0 such that, for t ≥ t1,
u(xˆ(t)) = u˜(xˆ(t)) ≥ 0.
Thus, for t ≥ t1, we obtain the following closed loop system:

˙ x
e
 =
 A+ bF bF
0 A− LC

 x
e
+
 b
0
 v
y =
[
C 0
]  x
e
 .
(5.3.1)
Let
A1 =
 A+ bF bF
0 A− LC
 .
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Since it can be easily seen (using the Routh - Hurwitz stability criterion (see footnote
on page 15) that, all the eigenvalues of A + bF lie in ℂ-, it turns out that A1 is stable.
Thus,
 x
e
 (t) = eA1t
 x
e
 (0) + ∫ t0 eA1(t−τ)
 b
0
 vdτ
= eA1t
 x
e
 (0) + ∫ t0 eA1(t−τ)dτ
 b
0
 v
= eA1t
 x
e
 (0) + A−11 (eA1t − I)
 b
0
 v
and, since eA1t → 0, it turns out that x
e
 (t)→ −A−11
 b
0
 v.
However,
A−11 =
 A+ bF bF
0 A− LC

−1
=
 (A+ bF )−1 − (A+ bF )−1 bF (A− LC)−1
0 (A− LC)−1
 .
Therefore,
−A−11
 b
0
 v = −
 (A+ bF )−1 bv
0

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and it turns out that
x(t)→ − (A+ bF )−1 bv.
Since it is easy to verify that − (A+ bF )−1 bv coincides with x∗, this proves our result.
5.4 Simulations
In the sequel, some simulation examples are presented for the control of the admin-
istration of the neuromuscular relaxant drug atracurium to patients undergoing surgery.
As it was already shown, it is possible to model this problem as a three compartmental
model described by the set of equations (4.1.1). Here, we consider that the patient’s real
model is given by (4.1.1), with the following values for the parameters (units = min−1):
k12 = 0.2131, k13 = 0.1, k21 = 0.1252, q1 = 0.1047, q2 = 0.01, q3 = 0.0836. Our aim is
to stabilize the system mass on the value M∗ = 3.5230 and the third component of the
system state (which corresponds to the drug effect) on x∗3 = 1.1169 (which, in an exact
modeling situation, can be shown to correspond to the typical 10% level of neuromuscu-
lar blockade (see Section 4.3)), applying the control law (5.1.2) to (4.1.1). The following
simulations illustrate the behavior of the mass and of the drug effect for the controlled
system for different observer gain vectors L. In the first and in the second simulations,
depicted in Fig. 5.1, it is assumed that L = 0. Note that this corresponds to a parallel
computation of the state based on initial conditions that are affected by error. However,
since the system turns out to be asymptotically stable, this initial error will converge to
zero. The other simulations show how the convergence can be accelerated by the choice of
suitable observer gains. In all simulations it is assumed that the initial error between the
estimated and the real state is e(0) = [3 1.8 2.5]T . In accordance with our theoretical
results, in all simulations one observes that the system mass converges toM∗ and the drug
effect converges to x∗3.
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(a)
(b)
(c)
Figure 5.1: Simulations for the neuromuscular blockade case for L = 0. Observer poles:
−0.0836,−0.0605 and −0.4925. (a) Simulation for the control of the system mass. Conver-
gence time: 159.7min. (b) Simulation for the control of the drug effect. Convergence time:
152min. (c) Drug dose.
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(a)
(b)
(c)
Figure 5.2: Simulations for the neuromuscular blockade case for L = [1.0227 − 0.5883 −
0.2266]T . Observer poles: −0.1,−0.11 and −0.2. (a) Simulation for the control of the system
mass. Convergence time: 92min. (b) Simulation for the control of the drug effect. Convergence
time: 104.7min. (c) Drug dose.
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(a)
(b)
(c)
Figure 5.3: Simulations for the neuromuscular blockade case for L = [2827 75951 29]T . Ob-
server poles: −10,−9 and −11. (a) Simulation for the control of the system mass. Convergence
time: 45.33min. (b) Simulation for the control of the drug effect. Convergence time: 77min.
(c) Drug dose.
Chapter 6
Conclusion
The results presented in this thesis were motivated by the good results of the control
law proposed in [Bastin and Praly (1999)] and [Bastin and Provost (2002)] when applied
to the control of the neuromuscular blockade level of patients undergoing surgery by means
of the continuous infusion of the muscle relaxant drug atracurium (which may be modelled
as a three-compartment system). Indeed, in [Magalhães et al (2005)], it was shown that,
due to the particular structure of this particular model, the proposed control law not
only leads the system total mass to the desired value, but also leads the system state
to an equilibrium point, which allows to control the aforementioned level. However, no
analysis was made of the effect of parameter uncertainty in the performance of this control
law. Since patient models are highly subject to uncertainties, in this situation robustness
is a very relevant issue. Therefore, our main purpose, while writing this thesis, was to
analyze the performance of this control law when applied to compartmental systems with
uncertainties, contributing to set a theoretical foundation for the practical implementation
of control procedure. Considering this goal, the mains contributions of this thesis are the
following ones.
For linear and uncertain fully outflow connected compartmental systems, it was shown
that the system total mass converges to a neighborhood of the desired value (Theorem
3.2.1). The limits of such a neighborhood can be expressed in terms of the uncertainty
bounds which allows to derive bounds for the asymptotical mass offset; furthermore, for
a wide range of compartmental systems with the same structure as the neuromuscular
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blockade control model and subject to parameter uncertainties it was proved that the
state of the controlled system converges to an equilibrium point whose total mass lies
within the aforementioned interval (Theorem 4.1.4).
In this thesis, two strategies were presented to decrease the steady state error for this
particular class of three-compartment systems: to adapt the considered control law during
the control process based on information about the obtained steady state error (section 4.2)
and, for the control of the neuromuscular blockade level, to combine different strategies
that, together, allow to improve the obtained results (section 4.4).
The performance of state-observers in the control of compartmental systems under un-
certainties in the initial state was also analyzed. Indeed, a state-observer and the proposed
state feedback control law were combined, and it was proved that, as expected, the system
total mass still converges to the desired value (Theorem 5.2.1). Moreover, for the consid-
ered class of three-compartment systems it was shown that the resulting mass control law
also allows reaching a desired steady state (Proposition 5.3.2). The results were illustrated
by several simulations for the control of the administration of a neuromuscular relaxant to
patients undergoing surgery which, in particular, show the relevance of incorporating an
observer for convergence acceleration, even in case the original system is asymptotically
stable.
In the future, is our aim to continue the work related to the control of the neuro-
muscular blockade level. In spite of the several studies that exist on this subject, there
is still a lot to be done. We intend to extend the results concerning state-observers to
general compartmental systems with parameter uncertainties. We also intend to develop
other strategies that provide an improvement of the control of the neuromuscular blockade
level and work in an extension of the results presented in Chapter 4 to a larger family of
compartmental systems.
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